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The joint modeling of longitudinal and time-to-event data is an active area of statistical
research that has received a lot of attention. The standard joint models, referred
to as univariate joint models, allow simultaneous modeling of a single longitudinal
outcome and a single time-to-event under an assumption of independent censoring.
The majority of the joint modeling research in the last two decades has focused on
extending and improving the univariate joint models. While many of the practical
applications involve data on multivariate longitudinal outcomes and multiple time-
to-events possibly informatively censored by some other terminal time-to-event, the
developments of joint models to analyze such complex data structure have not received
deserved attention. One other area of statistical joint modeling methods that remained
understudied is the joint analysis of multivariate longitudinal outcomes and multiple
ordered time-to-events. The joint models for recurrent events in existing literature can
be applied to analyze ordered time-to-events of the same type under an assumption that
all occurrences of the time-to-event are homogeneously influenced by the covariates.
However, in problems of ordered time-to-events of different types or of the same kind
where different occurrences may be impacted differently by the covariates, the current
methods may not be applied. Given the limitations in the existing body of joint
modeling literature, this research work aims to present joint modeling extensions with
the potentials of filling in the noted literature gaps.
In Chapter 2 of this dissertation, we presented a shared parameters Bayesian latent
trait joint frailty model for analyzing multivariate longitudinal outcomes and multiple
unordered non-terminal time-to-events in the presence of a terminal event inducing
v
dependent right censoring. We adopted a semiparametric latent trait generalized
mixed-effects approach to define the longitudinal submodel. Semiparametric hazard
regression models are used to model the non-terminal and terminal time-to-event
risks with multivariate non-terminal event frailties to account for the inter-event
associations. Chapter 4 introduces an extension of the joint model presented in
Chapter 2 for multivariate longitudinal outcomes and multiple ordered time-to-events.
For both the proposed models, Bayesian approaches of parameter estimation are
discussed, and Bayesian Monte Carlo Markov Chain (MCMC) dynamic prediction
algorithms for longitudinal outcomes and time-to-event risks are outlined. The finite
sample performances of the parameter estimation methods and dynamic prediction
algorithms are studied through statistical simulations for both the proposed models.
Before presenting the joint frailty model for multiple ordered time-to-events in
Chapter 4, we revisited a long-studied problem of estimating the survival functions
for multiple ordered time-to-events in Chapter 3. Given the complexities and un-
becomingness under certain assumptions of the current methods, we discussed two
straightforward and easy to compute approaches of estimating survival functions
of multiple ordered time-to-events. The first approach is non-parametric, based on
Kaplan-Meier survival estimates, and assumes independence between the consecutive
event times to estimate the marginal survival curves. The second approach is fully
parametric, assumes the consecutive event gap times to be log-normally distributed,
and estimates the marginal and conditional survival functions when the consecu-
tive event times may not be expected to be independent. Simulations studies were
performed to evaluate the finite sample properties of both the non-parametric and
parametric approaches at different sample sizes and censoring rates.
In addition to the extensive simulation studies, we have demonstrated applications
of all the proposed joint models, and survival function estimation approaches using
statewide surveillance data from South Carolina (SC) HIV/AIDS patients.
vi
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In many clinical studies that involve repeated measures, it is common to observe one
or more longitudinal outcomes (e.g., disease biomarkers), as well as one or more time-
to-event outcomes such as the onset of a disease, death, discontinuation of treatment,
dropout, etc. In many cases, the longitudinal measurements and the event times are
known to be correlated, or they share some important covariates. For example, lower
values of longitudinally measured CD4 cell counts may be associated with a higher risk
of some opportunistic diseases as well as death (Liu and Huang 2009). Furthermore,
the occurrence of the time-to-event may induce an informative censoring on the
longitudinal outcome observations (Hogan and Laird 1997a; Hogan and Laird 1997b),
which needs to be addressed while making inferences on the longitudinal outcomes
(Wu and Carroll 1988). Thus the analyses of data involving such association structures
require a framework that explicitly accounts for the underlying relationships between
the longitudinal outcomes and the time-to-event processes. Modeling the longitudinal
outcomes and time-to-events separately, for example, using linear mixed models
for longitudinal outcomes and Cox regression (with or without using longitudinal
outcomes as time-varying covariates) models for time-to-events, can, therefore, be
inefficient and may lead biased effect size estimates (Ratcliffe, Guo, and Ten Have 2004;
Prentice 1982). The statistical joint models offer an excellent means of simultaneously
modeling these correlated longitudinal and time-to-event processes and thus provide
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more accurate estimates of parameters and valid inferences on both the longitudinal
and time-to-event processes. In a broader sense, as outlined by Hickey et al. (2016),
the merits of jointly modeling the longitudinal and time-to-event data can be thought
of as firstly, improved inference for longitudinal outcomes subject after accounting for
the informative dropouts incurred by the time-to-event (Dupuy and Mesbah 2002);
secondly, improved inference for time-to-event outcomes, whilst taking account of how
the underlying changes in the longitudinal outcomes influence the time-to-event risk
(Wulfsohn and Tsiatis 1997); and finally, studying the relationship between the two
correlated processes (Henderson, Diggle, and Dobson 2000).
1.2 Joint Modeling Literature
The statistical research on joint models were initiated by the early works of De
Gruttola and Tu (1994), Self and Pawitan (1992), and DeGruttola and Tu (1992)
with applications in studying the disease progression and survival of AIDS patients.
Faucett and Thomas (1996) and Wulfsohn and Tsiatis (1997) have further studied
and introduced what is referred to as the standard joint model now-a-days. Since
then the joint modeling has been an extremely active statistical research area and
has developed a very rich body of literature that has been comprehensive reviewed by
Hogan and Laird (1997b), Tsiatis and Davidian (2004), Diggle, Sousa, and Chetwynd
(2008), Sousa (2011), Proust-Lima et al. (2014), Lawrence Gould et al. (2015), and
more recently by Hickey et al. (2016) and Hickey et al. (2018).
1.2.1 Standard Joint Model
If {yi(tij), ti, δi; i = 1, 2, . . . n, j = 1, 2, . . . ni} presents the structure of data observed
from n subjects where, yi(tij) is the measure of a longitudinal outcome for subject i
at visit j recorded at time tij from, ti = min (T ∗i , Ci) is the observed time to an event
of interest. The true event time T ∗i and the right censoring time Ci are assumed to be
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independent. δi is the event indicator (1 if the event is observed, 0 if censored). The
standard joint model for aforementioned data is formed with two submodels defined
for the longitudinal outcome and for the time-to-event. The longitudinal outcome is
modeled using a linear mixed-effects model
yi(t) = mi(t) + εi(t) (1.1)
mi(t) = Xi(t)β +Zi(t)αi
where, mi(t) denotes the true value of the underlying longitudinal covariate with error
at a set of few time points for each subject. The random-effect parameters (αi) and
the measurement error (εi) are assumed to be normally distributed as αi ∼ N(0,Σα)
and εi ∼ N(0, σ2ε ). The mixed-effects model gives the individual-specific time evolution
of the longitudinal outcome for estimating the time-to-event risk which is modeled
using a semiparametric hazard model as
λi(t |Hi(t),Wi) = λ0(t) exp [Wiγ +mi(t)ξ] , t > 0 (1.2)
where, Hi(t) = {mi(s), 0 ≤ s ≤ t} denotes the history of the true unobserved longitu-
dinal process up to time t,W is the vector of baseline covariates and the corresponding
vector of regression coefficients is denoted by γ. The parameter ξ quantifies the effect
of underlying longitudinal outcome on the time-to-event risk.
1.2.2 Joint Model Extensions
The standard methods for joint modeling (also referred to as univariate joint modeling)
allow simultaneous modeling of a single longitudinal outcome and a single mode of
failure under an assumption of independent right censoring. Many extensions of the
standard joint model have been developed in the subsequent years, including modeling
the hazard function as a function of history and rate of change in the longitudinal
outcome (Henderson, Diggle, and Dobson 2000), using cure mode for the time-to-event
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(Yu et al. 2004), and using nonparametric random-effects model for longitudinal
outcome (Brown, Ibrahim, and DeGruttola 2005; R. Brown and G. Ibrahim 2003).
In practice, however, in many study setups, the data can be more complex,
featuring multivariate longitudinal outcomes, multiple event times including recurrent
or competing events. Further, the assumption of independence between the event
times and censoring times may not always hold. A single modeling framework making
use of all the available information is advantageous and expected to improve the
predictions. Such multivariate joint models may also be regarded as an excellent
tool in personalized medicine research, as the models can provide the physicians
with better insights of the disease dynamics being studied, which may guide to the
most optimal choice of treatment for a patient at a specific time point (Hickey et al.
2016). In responses to the needs, the joint modeling literature has seen a vast array
of methodological developments in the past decade to jointly analyze the data on
multiple longitudinal outcomes and/or multiple time-to-events. Hickey et al. (2016)
presented an excellent review of the methodological advancements of joint models
concerning multivariate longitudinal outcomes.
When multivariate longitudinal outcomes are in interest, most researchers presented
extensions of the longitudinal submodel to tackle multiple continuous outcomes only.
Such studies include studies from Ibrahim, Chen, and Sinha (2004), Chi and Ibrahim
(2006), Hatfield, Boye, and Carlin (2011), Jaffa, Gebregziabher, and Jaffa (2014),
Musoro, Geskus, and Zwinderman (2015), and Tang and Tang (2015) among many
others. Some researchers also have focused on extending the longitudinal submodel
to incorporate multivariate longitudinal outcomes of other types and combinations
of different types as well. For instance, Huang et al. (2001) presented a joint model
for multivariate binary outcomes; Dantan et al. (2008), Proust-Lima et al. (2009),
Albert and Shih (2010a), and Liu and Li (2016) studied continuous [0, 1] bounded
longitudinal outcomes; Wang, Douglas, and Anderson (2002) and Li et al. (2012)
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used ordinal longitudinal outcomes, Rizopoulos and Ghosh (2011) used a mixture
continuous and binary outcomes, and Wang, Luo, and Li (2017); Wang and Luo
(2019) presented joint models for continuous and ordinal longitudinal outcomes. The
literature has also seen notable diversity in the approaches of modeling the multivariate
longitudinal outcomes. The majority of the studies used a multivariate generalized
linear mixed-effects model with the within-subject measurement errors being normally
distributed to define the longitudinal submodel for continuous, binary, and count
responses (Hickey et al. 2016). Tang and Tang (2015) used a multivariate skew-normal
distribution to avoid the outlier effects in estimates when studying the continuous
type multivariate longitudinal responses. To model the continuous [0, 1] bounded
longitudinal responses, Dantan et al. (2008), Proust-Lima et al. (2009), and Proust-
Lima, Dartigues, and Jacqmin-Gadda (2016) used a Beta transformation link function,
while Hatfield, Boye, and Carlin (2011), and Liu and Li (2016) used zero-one inflated
and zero-augmented beta regression model. Given the computational challenges in
multivariate joint models due to high-dimensional longitudinal outcomes and the
associated random-effects, researchers also have used a latent variable approach in
longitudinal submodel (He and Luo 2016; Wang, Luo, and Li 2017; He and Luo
2016). Li and Luo (2019) used multivariate functional regression for longitudinal
outcomes and proposed a Bayesian functional joint model for multivariate longitudinal
outcomes and a single time-to-event. The other advancements in the literature of
joint modeling with multivariate longitudinal outcomes include studies focused on the
distribution and correlation structure of random-effects. In cases of univariate joint
models, the inferences are, in general, reported to be robust to the misspecification
of random-effects (Zhu et al. 2012; Rizopoulos, Verbeke, and Molenberghs 2008).
However, in multivariate joint models, the total number of random-effects increases
with the increasing number of longitudinal outcomes. Thus the potential effects of
misspecification on parameter estimates and standard errors get amplified. Researchers
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have sought the options of modeling the random-effects semiparametrically to avoid
possible misspecification effects. Rizopoulos and Ghosh (2011), Tang, Tang, and Pan
(2014), and Tang and Tang (2015) used Dirichlet process prior for the random-effects
within a Bayesian framework. Other alternative approaches adopted by researchers to
avoid random-effects misspecification include treating the random-effects as nuisance
parameters (Song, Davidian, and Tsiatis 2002) and estimating the random-effects
entirely nonparametrically (Li et al. 2012).
In addition to the extensions of the longitudinal submodel, the joint modeling
literature also has grown with many extensions of the time-to-event submodel form the
simple case of a single time-to-event and independent censoring. Hickey et al. (2018)
presented a thorough review of the joint model extensions concerning the time-to-event
submodel. These advances in time-to-event submodel in statistical joint models can
broadly be divided into a few headings namely, competing risk time-to-events, multiple
time-to-events, and recurrent time-to-events.
A competing risks situation arises when an individual is exposed to the risk of
more than one possible types of time-to-events, and the probability of occurrence
of one event is hindered by another. A typical competing risk situation in clinical
studies can be described as studying the risk of death from different causes. Several
authors have considered extending the standard joint model for competing risk time-
to-events. Elashoff, Li, and Li (2007) extended the standard joint model to study
treatment failure or death among scleroderma lung disease patients and considered
disease-related dropouts to model as competing risk events using a mixture submodel.
In a sequel study (Elashoff, Li, and Li 2008), the same authors presented a joint model
using a cause-specific frailty hazard model for competing risk time-to-events. The
later studies that focused on the competing risk joint model essentially used a similar
approach as Elashoff, Li, and Li (2008) but offered some modifications in submodel
definition or in parameter estimation. Some of these later developments include using
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cause-specific hazard frailties as proportional to the random-effects in longitudinal
submodel (Williamson et al. 2008), using a Bayesian approach to estimate model
parameters (Hu, Li, and Li 2009), using t-distribution instead of normal for longitudinal
model measurement errors to achieve robustness (Li, Elashoff, and Li 2009), adjusting
the longitudinal submodel for ordinal data (Li et al. 2010). Andrinopoulou et al.
(2014) further extended competing risk joint model to accommodate two longitudinal
outcomes while using a Bayesian approach with B-splines to capture the non-linear
trends in the longitudinal outcomes observations.
In many practical settings, individuals may be subject to experience multiple
time-to-events of arbitrary order and researchers may be interested in studying the
association of these events with observed longitudinal outcome(s) and explaining the
risks of all of these unordered events. Even though such data may arise frequently
(e.g., studying the risks of comorbidities among the patients of any chronic disease),
not many authors have studied this problem in joint modeling framework. Huang
et al. (2001) presented the first study in literature that proposed a latent variable
joint model for bivariate event times using discrete-time log-linear models. Chi and
Ibrahim (2006) later derived an extension of joint model for two time-to-events using
a Poisson process to define the bivariate survival submodel. Tang, Tang, and Pan
(2014) presented Bayesian joint model for multivariate longitudinal outcomes and
unordered multiple time-to-events. Tang and Tang (2015) further extended the model
of Tang, Tang, and Pan (2014) for skew-normally distributed measurement errors
in longitudinal outcomes, and Tang, Tang, and Zhu (2017) presented an influence
analysis for model proposed by Tang and Tang (2015).
Data on recurrent time-to-events arise when the same non-terminal time-to-event
is observed multiple times in the observation period for an individual. Unlike the
case of unordered multiple time-to-events, joint models for recurrent time-to-events
received relatively higher level of attention from researchers and thus the literature
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has accumulated higher number of related methodological developments. Henderson,
Diggle, and Dobson (2000) first introduced an extension of standard joint model
applicable to a recurrent event. Han, Slate, and Peña (2007) presented a parametric
joint model for recurrent events after adopting the general recurrent event time model
of Peña and Hollander (2004) within the latent class model as in Lin et al. (2002).
Njagi et al. (2016) used a Weibull-gamma-normal model for recurrent time-to-event in
a felexible joint modeling framework allowing different types (continuous, binary, and
count) of longitudinal outcomes. Efendi et al. (2013) as well adopted a similar approach
and offered a joint model for recurrent time-to-event and continuous longitudinal
outcome with direct marginal interpretation. Shen, Huang, and Guan (2016) proposed
modeling a recurrent time-to-event in a joint modeling framework using proportional
semiparametric intensity model reframed as a conditional rate function for estimation.
A number of authors also have studied joint model extensions for recurrent time-
to-events in presence of dependent censoring induced by a terminal time-to-event. Liu,
Huang, and O’Quigley (2008) presented the first study of this kind with an application
to analyze medical cost data. Liu, Huang, and O’Quigley (2008) used a system of
three submodels including a random-effects model for longitudinal outcomes, a frailty
hazard model for recurrent event, and a proportional hazard model for the terminal
event. Liu and Huang (2009) used a more general shared frailty joint model to analyze
longitudinally measured CD4 cell counts and risk of recurrent opportunistic diseases
in presence of death among HIV/AIDS patients. Kim et al. (2012) proposed a similar
model for recurrent time-to-event in presence of a terminal event but used a flexible
transformation of cumulative intensities instead of direct hazard scale to model the
time-to-event outcomes. Król et al. (2016) introduced a joint frailty model for a
left censored longitudinal outcome, a recurrent time-to-event, and a terminal event.
More studies, among others, that proposed variations of joint models for longitudinal
outcomes, a recurrent time-to-event with informative censoring from terminal event
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include joint frailty model estimated by maximizing penalized log-likelihood (Mazroui
et al. 2012), and a joint model using an additive hazard model for the terminal
time-to-event (Che and Angus 2016).
Making advancement from a single recurrent time-to-event, Musoro, Geskus, and
Zwinderman (2015) developed a Bayesian joint frailty model for recurrent time-to-
events of different types and multivariate longitudinal outcomes. Mazroui et al. (2013)
proposed another version of joint frailty model for multivariate longitudinal outcomes,
two types of recurrent time-to-event in presence of a terminal event. Hof et al. (2017)
further proposed a joint frailty model for multivariate longitudinal outcomes and
multiple different recurrent events in presence of a terminal event. Hof et al. (2017)
used simulated maximum likelihood technique based on quasi-Monte Carlo integration
instead of fully Bayesian method for model estimation. Lin et al. (2017) suggested
a Bayesian joint frailty model for multi-type recurrent events and in presence of
dependent termination using nonparametric covariate functions defined by B-splines
for both recurrent and terminal time-to-events.
1.3 Dynamic Predictions
A novel use of joint models, which gained increasing interest in recent years, is to
obtain personalized prediction of future longitudinal outcome trajectories as well as
time-to-event risk at any time, given the subject-specific observation history up to the
time of prediction. The attractive feature of predictions using joint models is that
they can be updated dynamically as new data points are added to the observation
history and termed as dynamic predictions by many.
In accordance with the growing developments of joint models for complex data,
the needs for algorithm to draw dynamic predictions using these models grew as
well. There are a number of studies in literature that worked towards developing
algorithms for joint model dynamic predictions. Taylor, Yu, and Sandler (2005) first
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discussed a method of obtaining dynamic predictions in context of joint modeling
for disease progression and clinical recurrence following radiation therapy among
prostate cancer patients. They adopted a longitudinal-survival-cure joint model (Law,
Taylor, and Sandler 2002; Yu et al. 2004) and obtained the individualized predictions
using a Markov chain Monte Carlo (MCMC) algorithm. Proust-Lima and Taylor
(2009) proposed a dynamic prediction algorithm for recurrent time-to-event within
a joint latent class modeling framework (Lin et al. 2002; Proust-Lima et al. 2009).
Rizopoulos (2011) used a empirical Bayes Monte Carlo approach to estimate risk
of a target event and illustrated how it can be dynamically updated wihtin a joint
model for single longitudinal outcome and a single time-to-event. Taylor et al. (2013)
further presented a Bayesian approach using MCMC to dynamically predict both
the continuous longitudinal outcome and survival event probability. Blanche et al.
(2015) extended the dynamic prediction algorithm for competing risk time-to-events.
Rizopoulos, Molenberghs, and Lesaffre (2017) compared dynamic predictions using
joint models and landmark analysis (Van Houwelingen 2007), an alternative approach
for dynamically updating survival probabilities. Barrett and Su (2017) proposed a
straightforward dynamic prediction algorithm using a flexible joint model for a single
longitudinal outcome and a single time-to-event. Barrett and Su (2017) defined their
model using time-dependent random-effects with non-stationary covariance structure
(constructed by P-splines) to model time trends in each individual trajectory in
longitudinal outcome. Considering that the P-spline coefficients given the observed
data are distributed as multivariate-skew-normal, the algorithm of Barrett and Su
(2017) does not require posterior approximation while making predictions on the
time-to-event risk.
Most studies on dynamic predictions via joint models in the literature have
been restricted to the models of single continuous longitudinal outcome and single
time-to-event. However, in recent years, a few studies focused on discussing the
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dynamic prediction algorithms for more complex joint models. Wang, Luo, and Li
(2017) presented a Bayesian MCMC dynamic prediction algorithm in context of a
semiparametric latent trait joint model for multivariate longitudinal outcomes of
different types (continuous and ordinal) and a single time-to-event. Li and Luo (2019)
discussed MCMC dynamic prediction within a Bayesian functional joint modeling
framework for multivariate longitudinal outcomes and a single time-to-event. In
another recent study, Hof et al. (2017) derived a quasi-Monte Carlo approach drawing
dynamic predictions for a joint models of multivariate longitudinal outcomes and
multiple recurrent time-to-events in presence of a terminal event.
1.4 Aims and Structure of Dissertation
This research finds a number of gaps in existing multivariate joint modeling literature
and aims to make some novel contributions which are expected to be instrumental in
practical applications meeting the data setup as well as are expected to open windows
for further developments. The aims and structure of this dissertation are outlined in
following.
As reviewed in the Section 1.2.2, most of the statistical developments in joint
modeling literature have been concerned with a single longitudinal outcome and a
single time-to-event and only a few studies focused on joint models for multivariate lon-
gitudinal outcomes and multiple unordered time-to-events. The practical applications
of these studies are even further limited by certain assumptions of the models. For
example, the most recent development in this regards presented by Tang, Tang, and
Pan (2014), Tang and Tang (2015) ignored the correlations between the time-to-events
in their models. Further, each of the joint models in literature for multiple unordered
time-to-events assumed independent right censoring which may not be true in many
real life situation involving informative censoring possibly due to the presence of a
terminal time-to-event. In Chapter 2, we presented a semiparametric latent trait
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joint frailty model for multivariate longitudinal outcomes and multiple time-to-events
in presence of informative censoring by a terminal event. We used a fully Bayesian
approach for estimating the model parameters. We also present a MCMC framework
for dynamic predictions of future longitudinal outcome trajectories and time-to-events
risks. The proposed model and dynamic prediction methods are evaluated using statis-
tical simulations. We demonstrated an application of the proposed joint model using
the statewide South Carolina (SC) HIV/AIDS surveillance data. We jointly modeled
the longitudinally observed viral loads, CD4 cell counts, and selected HIV/AIDS
co-morbidities with death as the terminal and informative censoring event.
Chapter 3 and Chapter 4 of this dissertation focuses on statistical methods for
analyzing data involving non-recurrent multiple sequential time-to-events which are
mostly understudied in the current body of literature. In many applications, multiple
non-recurrent time-to-events may be observed in a specific sequence. In Chapter 3, we
presented a nonparametric maximum likelihood estimator (NPMLE) of the conditional
survival functions for multiple sequentially observed time-to-events. The proposed
NPMLE estimator was derived under the assumption of independence between the
consecutive event times, which however may not be true in all practical applications.
We further have proposed a multivariate log-normal modeling approach of estimating
the marginal and conditiona survival functions for sequential time-to-events, which
accounts for the dependence between the event times. We evaluated the proposed
estimators of survival functions using extensive statistical simulations and used them
to study the HIV viral load rebound behavior among SC HIV/AIDS patients diagnosed
with detectable viral load (VL).
There is a large body developments in the areas of joint modeling for single/multiple
non-recurrent/recurrent time-to-events. However, to the best of our knowledge, no
author ever have worked on analyzing non-recurrent multiple sequential time-to-events
in a joint modeling framework. Using a similar approach introduced in Chapter
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2, the Chapter 4 introduces a statistical joint model for multivariate longitudinal
outcomes and multiple sequential time-to-events. We presented the Bayesian approach
of parameter estimation and a MCMC algorithm of dynamic predictions. In addition
to statistical simulations to evaluate the proposed model, we presented an application
of the proposed model to analyze the longitudinally observed CD4 cell counts and the
HIV VL rebound events among SC HIV/AID patients diagnosed with detectable VL.
Chapter 5, the final chapter of this dissertation, presents a overall summary of




Joint Modeling of Multivariate Longitudinal
Outcomes and Multiple Time-to-Event Data in
the Presence of a Terminal Event
2.1 Introduction
For the past decades, joint statistical modeling has been a very active area of research.
As discussed in Chapter 1 as well as reviewed in other previous articles (Tsiatis
and Davidian 2004; Diggle, Sousa, and Chetwynd 2008; Sousa 2011; Proust-Lima
et al. 2014; Lawrence Gould et al. 2015; Hickey et al. 2016; Hickey et al. 2018)
contributions from many authors have enriched the joint modeling literature. However,
the majority of the advancements and extensions made after the standard joint
model introduced by (Faucett and Thomas 1996; Wulfsohn and Tsiatis 1997) focused
on the analyses of a single longitudinal outcome and a single time-to-event. In
many practical applications, though, it is often of interest to jointly model multiple
longitudinal outcomes with more than one time-to-events. For example, due to the
compromised immune system, HIV/AIDS patients frequently suffer from various
co-morbidities such as cardiovascular disease, diabetes, renal disease, liver disease,
cancer, and other co-occurring infections. Furthermore, analyzing co-morbidity risks
among HIV/AIDS patients requires adjustment for multiple longitudinally observed
covariates such as CD4 cell counts, viral load, and other available biomarkers. Making
the data structure further complicated, there may other terminal events be present
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and induce dependent or informative censoring on the non-terminal time-to-events.
The independent censoring assumption used in the standard joint model and it’s
extensions no longer hold in such situations. It is thus of importance to develop
statistical joint models capable of analyzing multivariate longitudinal outcomes and
multiple time-to-event jointly after accounting for all sources of correlations between
longitudinal and time-to-event, both non-terminal and terminal (if present), data.
Only a few studies in the literature (Huang et al. 2001; Chi and Ibrahim 2006;
Tang, Tang, and Pan 2014; Tang and Tang 2015; Tang, Tang, and Zhu 2017) sought
to make methodological progresses for jointly analyzing the correlated data collected
on multivariate longitudinal outcomes and multiple time-to-events. There are other
extensions of joint models applicable to multivariate longitudinal outcomes and
multiple time-to-event of recurrent nature (Król et al. 2016; Hickey et al. 2018).
However, we are keeping our discussion in this chapter limited to the joint modeling
of multivariate longitudinal outcomes and multiple unordered time-to-events of non-
recurrent nature.
Huang et al. (2001) made the first attempt to extend the joint model to more than
one time-to-event and proposed a latent variable joint model for bivariate event times.
To analyze data on multiple repeated mental health items and the events of starting
alcohol and tobacco use, Huang et al. (2001) used a three components joint model.
Huang et al. (2001) assumed a longitudinal latent process for psychiatric distress,
given the interventions and covariates, and utilized a marginal model. A logistic
regression model was then used to model the repeated mental health items given the
underlying longitudinal process. Finally, discrete-time log-linear hazard models were
used to model the events of alcohol and tobacco use initiation given the intervention,
covariates, and latent process. Despite being one of the first initiatives towards
addressing the problem of jointly modeling multivariate longitudinal outcomes and
more than one time-to-event, the work of Huang et al. (2001) was limited to only two
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time-to-events, assumed independence between the time-to-events, and not applicable
to studies where informative censoring from terminal time-to-event is present.
Chi and Ibrahim (2006) introduced an extension of the joint model for multidimen-
sional longitudinal and time-to-event outcomes. The work of Chi and Ibrahim (2006)
was primarily motivated by a dataset from a clinical trial that monitored the breast
cancer progression as the treatment outcome as disease-free survival (DFS) and overall
survival (OS) among a group of women receiving chemotherapy. Patients’ quality of
life (QOL) was hypothesized to carry prognostic information to be predictive of breast
cancer progression. Chi and Ibrahim (2006) proposed a joint likelihood approach
to jointly model the multidimensional QOL and the bivariate time-to-event random
variables DFS and OS. A multivariate mixed-effects model was used to explicitly
capture the within and between dependence among the repeatedly measured QOL
indicators. A shared frailty, assumed to have a positive stable distribution, was used
to induce the correlation between two time-to-event (DFS, OS). Given the common
frailty, their time-to-events were assumed to be independent. The time-to-events were
assumed to be conditionally independent, given the latent QOL trajectory function.
The linking between longitudinal and time-to-event submodels was made by using
current values parameterization. The model from Chi and Ibrahim (2006) again was
limited to being used for only two time-to-event and did not consider any possibility
of informative censoring.
Tang, Tang, and Pan (2014) presented a Bayesian semiparametric joint model
for multivariate longitudinal outcomes and unordered multiple time-to-events. Tang,
Tang, and Pan (2014) used multivariate generalized linear mixed-effects model for
longitudinal outcomes. However, the parametric distribution of the random effects in
the longitudinal submodel was relaxed by using a centered Dirichlet process mixture
model instead of a multivariate normal distribution. The time-to-events were modeled
through hazard regression using piecewise constant baseline hazards. Tang and Tang
16
(2015) further extended the model of Tang, Tang, and Pan (2014) for skew distributed
measurement errors in longitudinal outcomes. In this later development, they used a
semiparametric multivariate generalized linear mixed-effects model with skew-normal
errors to model the longitudinal outcomes. Tang, Tang, and Zhu (2017) further
presented an Bayesian influence analysis for their model proposed in Tang and Tang
(2015). Despite offering a joint model applicable to multivariate longitudinal outcomes
and multiple time-to-events, and studying alternatives specifications of longitudinal
outcomes and random-effects distributions, these models ignored the correlation
between the time-to-events as well as assumed independent right censoring for the
events. The ‘no correlation between the time-to-events’ assumption may not be true
in practice. Further, the models may not be applicable in the presence of any terminal
event causing informative censoring for the non-terminal events.
Given the practical needs and the gap in the literature, in this study, we present a
shared parameter Bayesian joint frailty model for multivariate longitudinal outcomes
and multiple time-to-event in the presence of informative censoring by a terminal
event. In an analysis of data, our proposed model accounts for correlations from all
potential sources, including the longitudinal outcomes and both the non-terminal and
terminal time-to-events. We discuss the Bayesian estimation algorithm for the model
parameters and Markov chain Monte Carlo algorithm of obtaining dynamic predictions.
We present statistical simulation studies evaluating the model parameter estimation
and the dynamic prediction performances and used data from South Carolina (SC)
HIV/AIDS data show an application of the proposed model.
The rest of the chapter is organized as follows. The proposed model and the
parameter estimation algorithm are presented in Sections 2.2 and 2.3, respectively.
Section 2.4 outlines the dynamic prediction method, and predictive evaluation criteria
are shown in Section 2.5. Section 2.6 presents the simulation studies, Section 2.7
demonstrates an application, and finally, a discussion is presented in Section 2.8.
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2.2 Methods
Let us consider that a set of n subjects are followed over time. Data onM longitudinal
outcomes and K non-terminal as well as a terminal time-to-events are collected for
each. Let yijm be the observed value of mth longitudinal outcome (m = 1, 2, . . . ,M)
at time tij for the ith individual where i = 1, 2, . . . , n and j = 1, 2, . . . , ni.
For ith (i = 1, 2, . . . , n) individual, let T ∗i be the true terminal event time, and Ci
is the independent right censoring time defined by the end of the follow-up period.
The observed terminal time-to-event data for the ith individual can then be denoted
by (Ti, δi), where Ti = min(T ∗i , Ci) denotes the time until the event is observed or
censored, and δi = I(Ti = T ∗i ) is the terminal event indicator. δi = 1 indicates that
the terminal event is observed while δi = 0 implies censored terminal event.
Let us further consider that T ∗ik be the true event time for kth (k = 1, 2, . . . , K) non-
terminal time-to-event. The non-terminal time-to-events can be censored by the time-
to-the-terminal-event (Ti, for individuals that experience the terminal time-to-event in
follow-up period) or by the independent right censoring time (Ci, for individuals that
do not experience the terminal time-to-event in follow-up period). The ith individual’s
observations for the kth non-terminal event thus can be denoted by Tik, δik, where
Tik = min(T ∗ik, T ∗i , Ci) denotes the event/censoring time, and δik = I(Tik = T ∗ik) is
the respective event indicator. Figure 2.1 in the following demonstrates a graphical
example of the described data generating process from multivariate longitudinal
outcomes and multiple time-to-event.
We propose a joint statistical model for the data collected on multivariate longitu-
dinal outcomes and time-to-events (both non-terminal and terminal) in a process, as
shown in Figure 2.1. We define separate submodels for the longitudinally observed
outcomes possibly of mixed types, non-terminal time-to-events, and the terminal
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Figure 2.1: A demonstration of data collection process on multivariate longitudinal
outcomes, and multiple non-terminal time-to-events and a terminal time-to-event.
2.2.1 The Longitudinal Submodel
A multivariate semiparametric latent trait generalized linear mixed model (LTGLMM)
(Wang, Luo, and Li 2017) is used for the longitudinally observed outcomes to model the
simultaneous development of them through time and to account for the interrelation
between outcome values from same individual, as well as the between individual
dependency over time. Building the semiparametric LTGLMM involves two steps.
In the first step, it is assumed that there is a univariate latent trait representing the
multivariate longitudinally observed outcome process. Let Γi(t) denotes the value of
latent trait for ith individual at any observation time t. The mth (m = 1, 2, . . . ,M)
longitudinally observed outcome yim(t) for ith individual at time t then could be
expressed as a function of the latent trait as
ηijm(t) = fm [µijm(t)] = ϕm + Γi(t)ψm + εijm(t), (2.1)
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where, yijm(t) = yim(tij) is the observed value of mth (m = 1, 2, . . . ,M) longitudinal
outcome for ith (i = 1, 2, . . . , n) individual at time tij (j = 1, 2, . . . , ni). We assume
yijm(t) to follow a distribution in the exponential family with mean µijm(t). The
term εijm(t) in Equation (2.1) denotes the measurement errors associated with the
mth longitudinal outcome. The measurement errors for the M longitudinal outcomes
εij(t) = (εij1(t), εij2(t), . . . , εijM(t)) are assumed to be distributed as multivariate
normal with mean vector 0 and variance-covariance matrix Σε, i.e. εij(t) iid∼N (0,Σε).
The parameters ψm estimate the expected change in yijm for an unit increase in
the latent trait Γi(t) and ϕm = E [yijm(t)|Γi(t) = 0]. For a continuous numeric mth
longitudinal outcome the model in Equation (2.1) can be written as in Equation (2.2)
while the Equation (2.3) presents the model for a dichotomous longitudinally observed
outcome.
yijm(t) = ϕm + Γi(t)ψm + εijm(t) (2.2)
logit [Pr (yijm(t) = 1)] = ϕm + Γi(t)ψm (2.3)
We use a second level semiparametric linear mixed model to model the dependence of
latent trait variable Γi(t) on the observed characteristics of the study subjects
Γi(t) = Xi(t)β +Zi(t)αi + Gi(t), (2.4)
where, Xi is the vector of observed fixed effects covariates for ith individual, and
β is the corresponding column vector of fixed effects; αi is the column vector of
random effects, and Zi is corresponding covariate vector for the random effects for
ith individual which are assumed to be normally distributed as N (0,Σα). The term
Gi(t) in model Equation (2.4) denote an unknown twice continuously differentiable
smoothing function of time (t). The smoothing function allows additional flexibility
and smoothing in modeling the effects of the covariates on the latent trait. To
approximate the unknown smoothing function Gi(t), we use a truncated power series
spline (Ruppert, Wand, and Carroll 2003). Using the knots κ = (κ1, κ2, . . . , κR), the
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where, (t− κr)+ = t− κr if t > κr and 0 otherwise. φ = (φ1, φ2, . . . , φR)
′ is the vector
of spline coefficients and assumed to be distributed as N(0, σ2φI) to avoid overfitting
(Crainiceanu, Ruppert, Wand, et al. 2005; Ruppert, Wand, and Carroll 2003). To
ensure the sufficient number of subjects between the adjacent knots, we choose the
location of the rth (r = 1, 2, . . . , R) knot to be [(r + 1)/(R + 2)]th quartile of the
unique observation times for the longitudinal outcomes. Ruppert (2002) and Eilers
and Marx (1996) suggested using a moderately large number of knots (usually between
5 and 20) to ensure enough flexibility and sufficient smoothness in approximations
with penalized splines. However, Tang, Tang, and Zhu (2017) and Tang and Tang
(2015) reported a little effect of the selection of the number of knots on parameter
estimation in their models.
The Equations (2.1) and (2.4) together present a parsimonious semiparametric
multivariate LTGLMM for the longitudinal outcomes. The parsimony is obtained
from the reduced number of random effects as the derived model uses a single latent
trait to represent the M different longitudinal outcomes (Wang, Luo, and Li 2017).
2.2.2 The Time-to-Event Submodels
The second submodel is a time-to-event model, for kth (k = 1, 2, . . . , K) non-terminal
time-to-event, sharing the longitudinal latent trait and uses correlated time-to-event
specific frailties. The longitudinal outcomes are considered to influence the risk of
time-to-event at any time point through the latent trait. We consider λik(t) be the
hazard of the kth time-to-event at time t for ith individual and use a hazard model as
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λik [t|yi(t),Wik(t)] = λ0k(t) exp [Wik(t)γk + Γi(t)ϑk + ωik] , (2.6)
where, yi(t) denotes the history of the true unobserved longitudinal outcomes process
up to time point t. λ0k(.) is the baseline hazard function for kth time-to-event; Wik(t)
is the vector of observed covariates for ith individual at time t; γk is the column
vector of effect coefficients for covariatesWik(t). It is notable that Xi(t) in the model
Equation (2.4) for Γi(t) andWi(t) in the model Equation (2.6) for λik [t|yi(t),Wik(t)]
may have some common fixed effect covariates. Ibrahim, Chu, and Chen (2010)
offered an explanation for the effects of such common covariates. For instance, if βc
and γck respectively are the effect coefficients for a covariate common in Xi(t) and
Wik(t) then βc present the covariate effects on the longitudinal latent trait while
γck and (γck + ϑkβc) respectively measure the direct and total covariate effects on
the kth non-terminal time-to-event risk. For individual i, the association parameter
ϑk measures the effect of the latent trait Γi(t) on the risk of kth (k = 1, 2, . . . , K)
non-terminal time-to-event event at time t. For instance, ϑk = 0 implies that there is
no effect of the latent trait on the risk of kth non-terminal time-to-event.
The terms ωik in Equation (2.6) are the time-to-event frailties. The term ‘frailty’
was first introduced by Vaupel, Manton, and Stallard (1979). Vaupel, Manton, and
Stallard (1979) used frailty in univariate time-to-event model while the applications
in multivariate models were promoted by Clayton (1978), Oakes (1982), Oakes (1989),
Yashin and Iachine (1995), and Hougaard (2012) among others. The idea of using
frailty offers a suitable way to introduce random effects in time-to-event models
to account for the association as well as the unobserved heterogeneity in subjects.
Individuals with higher frailties are supposed to be more ‘frail’ or ‘prone’ to experience
the time-to-event in interest earlier than individuals with lower frailties. The frailty
vector ωi = (ωi1, ωi1, . . . , ωiK) in the model Equation (2.6) is assumed to have a
multivariate normal distribution with mean 0 and covariance matrix Σω, whose off-
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diagonal elements govern the correlation among risks of different time-to-events. For
example, a positive off-diagonal element σω,kk′ of the matrix Σω indicates a positive
correlation between the risks of events k and k′, where k, k′ = 1, 2, . . . , K, and k 6= k′.
Note that the proposed model assumes no correlation between the random effects
(αi) of the longitudinal submodel for the latent trait in Equation (2.4) and the
frailties (ωi) for the non-terminal time-to-events in Equation (2.6). However, it is also
possible to consider the random effects and frailties to be correlated and the joint
distribution can be assumed to an (M +K) dimensional multivariate normal. Given
the independence assumption in the current model, the joint distribution of αi and





As a specified and smoothed baseline hazard function is required for predicting
individual specific survival probabilities, we again adopt a truncated power series
spline (Ruppert, Wand, and Carroll 2003) approximation for the baseline hazard
functions λ0k(t) in Equation (2.6). The truncated power series spline approximation





= VkR(t) ζk, (2.7)
where, χk = (χk1, χk2, . . . , χkR) are the knots, and (t− χkr)+ = t− χkr if t > χkr and
0 otherwise. ζk = (ζk1, ζk2, . . . , ζkR)
′ is the vector of spline coefficients and assumed
to be distributed as N(0, σ2ζkI) to avoid overfitting (Crainiceanu, Ruppert, Wand,
et al. 2005; Ruppert, Wand, and Carroll 2003). Location of the rth (r = 1, 2, . . . , R)
knot (usually 5 to 20 knots) for the kth non-terminal time-to-event is chosen to be
[(r + 1)/(R + 2)]th quartile of the unique kth event times.
23
We further take that λi(t) presents ith individual’s risk of the terminal event at
time t. Considering λ0(.) as the baseline hazard function; γ to be the effects vector
for the observed covariates Wi(t), we model the terminal event risk as
λi [t|yi(t),Wi(t)] = λ0(t) exp [Wi(t) γ + Γi(t)ϑ+ ωi ξ] , (2.8)
where, the coefficient ϑ and the coefficient vector ξ = (ξ1, ξ2, . . . , ξK)
′ measure the
effects of the longitudinal latent traits and the K non-terminal time-to-event frailties
respectively on the terminal event risk at time t. A truncated power series spline
(Ruppert, Wand, and Carroll 2003) is again used for approximation of the terminal
event baseline hazard function. The truncated power series spline approximation of





= VR(t) ζ, (2.9)
where, χ = (χ1, χ2, . . . , χR) are the knots, and (t − χr)+ = t − χr if t > χr and 0
otherwise. ζk = (ζk1, ζk2, . . . , ζkR)
′ is the vector of spline coefficients and assumed
to be distributed as N(0, σ2ζkI) to avoid overfitting (Crainiceanu, Ruppert, Wand,
et al. 2005; Ruppert, Wand, and Carroll 2003). To ensure sufficient smoothness in the
baseline hazard functions, a large number (usually between 5 and 20) knots are used
(Ruppert 2002; Eilers and Marx 1996). Location of the rth (r = 1, 2, . . . , R) knot for
the kth non-terminal time-to-event is chosen to be [(r + 1)/(R + 2)]th quartile of the
unique event times.
2.3 Bayesian Estimation
In the joint modeling literature, the estimation methods used by researchers include
three general categories: maximum likelihood approach, two-stage approach, and
Bayesian Markov chain Monte Carlo (MCMC). As the name implies, the two-stage
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approach, discussed in many studies (Sweeting and Thompson 2011; Albert and Shih
2010b; Lin, Taylor, and Ye 2008; Dafni and Tsiatis 1998; Tsiatis, Degruttola, and
Wulfsohn 1995), estimates the joint model parameters in two stages. While in the first
stage, only the longitudinal model parameters estimated, the second stage estimates
the time-to-events parameters using the predicted longitudinal outcomes as true
exposure in a time-dependent hazard model. Despite being computationally simple,
the two-stage approach of estimation has been criticized for incurred bias and loss of
efficiency resulting from ignoring the time-to-event information when estimating the
longitudinal model parameters (Sweeting and Thompson 2011; Albert and Shih 2010b;
Faucett and Thomas 1996). In contrast to the two-stage approach, both the maximum
likelihood and Bayesian MCMC approaches make use of all the data (longitudinal and
time-to-events) to form a joint likelihood and estimate the parameters simultaneously.
However, due to the added complexity of multivariate longitudinal outcomes and
multiple time-to-event, the use of maximum likelihood estimation of joint models has
been mainly limited to the models with only a single longitudinal outcome and a
single time-to-event (Rizopoulos 2012; Huang, Dagne, and Wu 2011; Tseng, Hsieh,
and Wang 2005; Tsiatis and Davidian 2004; Wulfsohn and Tsiatis 1997). Yang, Yu,
and Gao (2016), for the first time, used a maximum likelihood estimation approach
using the expectation-maximization (EM) algorithm for joint models multivariate
longitudinal outcomes and a single time-to-event. The usage of Bayesian MCMC
approach, on the other hand, has grown as the developments and applications joint
models for multivariate longitudinal outcomes and multiple time-to-event gained focus
(Wang, Luo, and Li 2017; He and Luo 2016; Luo and Wang 2014; Rizopoulos and
Ghosh 2011; Chi and Ibrahim 2006; Brown, Ibrahim, and DeGruttola 2005; R. Brown
and G. Ibrahim 2003).
In addition to being relatively easy to implement and being more straightforward to
handle the complex models, the Bayesian MCMC estimation enjoys other advantages
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over the maximum likelihood approach. For instance, the Bayesian MCMC method
can provide an estimate of the exact posterior distribution of the parameters with
asymptotic standard errors while the maximum likelihood approach provides only
point estimates of the parameters (Dunson 2007). Further, when the sample size is
small, the Bayesian MCMC algorithm exhibits better performance compared to the
maximum likelihood approach (Lee and Song 2004).
In this study, we use a fully Bayesian MCMC estimation approach to estimate the
parameters of the proposed model. Under the assumption of conditional independence
of shared parameter joint models, we write the log posterior for the ith individual as













where, yi = {yijm; j = 1, 2, . . . , ni,m = 1, 2, . . . ,M} is the set of longitudinal outcome
observations collected from ith individual and θ is the vector of all population-level
model parameters in Equations (2.1), (2.4), (2.6), and (2.8). The log-posterior can be
re-written as













where, ∑nij=1 logPr (yijm(t)|αi,θ) is the log-posterior contribution of ith individual
for the mth longitudinal outcomes submodel. The terms logPr(Tik, δik|αi,ωi,θ) and
logPr(Ti, δi|αi,ωi,θ) denote the ith individual’s log-posterior for the kth non-terminal
and the terminal time-to-events, respectively. logPr(αi|θ) is the ith individual’s
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log-posterior for the distribution of random-effects in the longitudinal submodels,
logPr(ωi|θ) is the ith individual’s log-posterior for the distribution of frailty terms
in non-terminal time-to-event submodels, and finally, the term logPr(θ) represents
the joint prior distribution across all the remaining population-level parameters. The
log-posterior for the kth k = 1, 2, . . . , K non-terminal event submodel in Equation
(2.11) can be written as

















where, the hazard function λik(Tik|αi,ωi,θ) is given by Equation (2.6). The integral
in the definition of survival function in Equation (2.12) does not have an analytical
solution. To approximate the integral, we use Gauss-Kronord quadrature technique.
Usage of standard numerical integration techniques such as Monte Carlo and Gaussian
quadrature can be found in joint modeling literature (Rizopoulos 2011; Tsiatis and
Davidian 2004; Henderson, Diggle, and Dobson 2000). With Q nodes, the Gauss-














where, wq and sq, respectively are the standardized weights and locations (abscissa)
for quadrature node q (q = 1, 2, . . . , Q) (Laurie 1997). We choose Q = 15 nodes for the
approximations. Similarly, for the terminal time-to-event submodel, the log-posterior
can be written as




where, the hazard function λi(Ti|αi,ωi,θ) is given by Equation (2.7) and a Q nodes















where, wq and sq, respectively are the standardized weights and locations for qudrature
node q (q = 1, 2, . . . , Q).
In our Bayesian estimation algorithm, we assume vague priors for all the model
parameters. We assume the prior distribution N(0, 100) for all population-level
parameters; Uniform[0, 1] for all correlation parameters in covariance matrices; and
Inverse-Gamma(0.01, 0.01) for all variance parameters. To obtain the samples from
full conditional posteriors of the parameters, we used Hamiltonian Monte Carlo (Duane
et al. 1987) and No-U-Turn sampler (Hoffman and Gelman 2014) implemented in a
probabilistic programming language, Stan (Carpenter et al. 2017). Stan has been
reported to be efficient in achieving faster convergence and requiring a lower number
of samples compared to other Bayesian languages such as BUGS (Hoffman and Gelman
2014). To estimate the model parameters, we used four parallel Markov chains, each
with 2,000 iterations, where the first 1,000 iterations were discarded as burn-in. We
used the Gelman-Rubin diagnostic to ensure the convergences by observing the scale
reduction factor R̂ of all parameters to be less than 1.1 (Gelman et al. 2013).
2.4 Dynamic Prediction Algorithm
One of the most important advantages of joint models is their capability of providing
dynamic predictions. In this section, we discuss the algorithms for making individual-
specific dynamic predictions on the longitudinal outcome trajectories as well as the
risk of non-terminal and terminal time-to-event from the estimated proposed joint
model.
Let us consider that Dn = {yi, Ti, Ti1, . . . , TiK , δi, δi1, . . . , δiK , i = 1, 2, . . . , n} de-
notes the collection of outcomes data from the sample used to fit the joint model.
Let us call these data as the training data. Let us consider that an individual ι not
in the model training dataset has been followed until time tobs and has not expe-
rienced the terminal event yet. Given the follow-up history of subject ι until the
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time tobs, we can calculate the predicted longitudinal outcome trajectories as well
as the conditional survival/failure probabilities for non-terminal and terminal events
until some time point t′ > tobs. Let Dι(tobs) = (yoι , T oι , T oι1, . . . , T oιK , δoι , δoι1, . . . , δoιK)
denotes the follow-up history of the subject ι until tobs. Here, the indicator vector
(δoι , δoι1, . . . , δoιK) denotes the individual ι’s status of the terminal and non-terminal
time-to-events by the observation time tobs. Under the assumption that the individual
ι has not experienced the terminal event by tobs, we have T oι = tobs and δoι = 0 as being
right-censored by the observation time tobs. The observations on the non-terminal
time-to-events, (T oιk, δoιk; k = 1, 2, . . . , K), can also be defined in similar fashion.
The most important step for obtaining the dynamic predictions on the longitu-
dinal outcomes trajectories and the time-to-event risks is to obtain samples for the
individual ι’s random effects and frailties (αι, ωι) from their joint posterior distri-
bution. If we are interested in dynamically predicting the risk of kth non-terminal
event for individual ι who has not experienced the terminal event by the observation
time tobs, we then need to draw samples of random-effects and frailties from the
posterior distribution Pr [αι,ωι |T ∗ι > tobs, T ∗ιk > tobs,Dι(tobs),θ]. Let us consider θ(`)
(` = 1, 2, . . . ,L) denotes a vector of sample from the posterior distributions of the
population-level parameter vector θ. Then conditioning on the `th posterior sample
θ(`), `th sample of the random effects and frailties can be drawn from their joint
posterior distribution using the Bayes theorem as outlined in following,








Pr [T ∗ι > tobs, T ∗ιk > tobs,Dι(tobs) |θ(`)]
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where, the survival functions for the kth, k′th (k, k′ = 1, 2, . . . , K) non-terminal, and

























and the cumulative hazard functions can be computed using the Gauss-Kronord
quadrature outlined in Equations (2.13) and (2.15), respectively. Note that the implicit
conditioning on the observed covariates Xιm,Zιm,Wιk, and Wι are suppressed for
notational simplicity.
For each sample θ(`) (` = 1, 2, . . . ,L) of the population level parameters, we draw






using an adaptive rejection
Metropolis algorithm (Gilks, Best, and Tan 1995) and retain the final sample. Given
that the individual ι doesn’t experience the terminal event by time t′, the observation
history then gets updated to Dι(t′). The joint posterior distribution of random effects
and frailties is updated to Pr [αι,ωι |T ∗ι > t′,Dι(t′),θ], and we can draw new samples
to dynamically update the predictions.





ι , ` = 1, 2, . . . ,L
)
drawn for the individual ι, the
predictions on the longitudinal outcomes and the time-to-event risks can be obtained
by plugging in the parameter values in the respective model equations. For instances,
the `th predicted value for a numerical continuous and a binary longitudinal outcomes
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= ϕ(`)m + Γ(`)ι (t′)ψ(`)m , (2.18)




. Each parameter is replaced using the corresponding
element in (θ(`),α(`)ι ,ω(`)ι , ` = 1, 2, . . . ,L) and the `th value of the latent trait at time
t′ is obtained as
Γ(`)ι (t′) = Xι(t′)β(`) +Zι(t′)α(`)ι +UR(t′)φ(`) (2.19)
The `th value of ιth individual’s hazards at time t′ for the non-terminal and










∣∣∣α(`)ι ,ω(`)ι ] = λ0(t′) exp [Wι(t′)γ(`) + Γ(`)ι (t′)ϑ(`) + ω(`)ι (t′) ξ(`)] (2.21)
Given the follow-up history Dι(tobs), we can then compute the conditional failure
probability for the kth non-terminal by time t′ as




Pr [T ∗ιk ≤ t′ |T ∗ιk > tobs,Dι(tobs),αι,ωι,θ]×
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Pr [αι,ωι | Dι(tobs),θ] d(αι, ωι) (2.22)
Similarly, given the follow-up history Dι(tobs), to get dynamic predictions on the
terminal event risk, we draw samples from posterior distributions of random-effects
and non-terminal event frailties defined as
Pr [αι,ωι |T ∗ι > tobs,Dι(tobs),θ] =
Pr
[
T ∗ι > tobs,Dι(tobs),αι,ωι
∣∣∣θ(`)]
Pr [T ∗ι > tobs,Dι(tobs) |θ(`)]
∝ Pr
[




























and the conditional failure probability for the terminal event by time t′ as given the
follow-up history can be obtained as




Pr [T ∗ι ≤ t′ |T ∗ι > tobs,Dι(tobs),αι,ωι,θ]×
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Pr [T ∗ι ≤ t′ |T ∗i > tobs,αι,ωι,θ]×
K∏
k=1
Pr [T oιk, δoιk |αι,ωι,θ]×















































Pr [αι,ωι | Dι(tobs),θ] d(αι, ωι) (2.24)
Due to the multidimensional integral with respect to (αι, ωι) involved in Equations
(2.22) and (2.24), we can approximate π̂ιk(t′|tobs) and π̂ι(t′|tobs) using the Monte Carlo
method by plugging in the already drawn L posterior samples of population and
individual-level parameters (Rizopoulos 2011). The `th (` = 1, 2, . . . ,L) approximation



















































































Once the L posterior values are obtained for the longitudinal outcomes and the
event probabilities, the predictions can be obtained by computing the summaries (e.g.,
mean, median, quantiles) of the posterior value distributions.
2.5 Assessing Model Predictive Performance
It is necessary to assess the performance of the proposed dynamic prediction algorithms.
For the predictive accuracy of the time-to-event outcomes, one can use the measures
of discrimination and calibration (Wang, Luo, and Li 2017; Desmée et al. 2017). The
measure of discrimination quantifies how well the model discriminates individuals
who had the event in interest from those who did not have. A measure of calibration,
on the other hand, quantifies how close the predicted outcomes are to the observed
outcomes.
In this study, we focus on the prediction of time-to-event risks to assess the
predictive performance of the proposed joint model. For such an assessment, we use
the areas under curve (AUC) for the time-dependent receiver operating characteristics
(ROC) curves as a measure of discrimination (Li, Greene, and Hu 2018), and expected
dynamic Brier score (DBS) as a measure of calibration (Sène et al. 2016; Proust-Lima
et al. 2014).
34
2.5.1 Area Under ROC Curve
The receiver operating characteristics (ROC) curve has been used in the evaluation of
classification and prediction performances in medical sciences involving continuous
biomarkers and binary disease conditions (Zhou, McClish, and Obuchowski 2009;
Pepe 2003). However, binary classification of individuals into the event and non-event
groups may not be appropriate without accounting for the time-to-event data as
the event status can only be assigned relative to a specific time point (Li, Greene,
and Hu 2018). Heagerty, Lumley, and Pepe (2000) extended the traditional ROC
curve analysis of binary event data and proposed the concept of time-dependent ROC
curve for time-to-event data where the event status changes over time and can be
defined over a specific horizon of time. Among the other subsequent developments (Li,
Greene, and Hu 2018; Song and Zhou 2008; Chambless and Diao 2006), Li, Greene,
and Hu (2018) proposed a simple method, that we use in this study, to estimate the
time-dependent ROC curve and AUC for right-censored time-to-event data.
Let us consider that we have obtained the individual predicted probabilities of
experiencing the kth (k = 1, 2, . . . , K) non-terminal time-to-event by time t′ given the
observation history till time tobs using the algorithm described in Section 2.4. For any
given cut-point c ∈ (0, 1), we can define the time-dependent sensitivity and specificity
as
Sensitivity : Pr [πik(t′|tobs) > c |T ∗ik > tobs, I(tobs < T ∗ik ≤ t′) = 1] , (2.27)
Specificity : Pr [πik(t′|tobs) ≤ c |T ∗ik > tobs, I(tobs < T ∗ik ≤ t′) = 0] , (2.28)
where, I(tobs < T ∗ik ≤ t′) indicates if the ith individual experienced the kth non-
terminal time-to-event during the interval (t, t′]. Let us label the individuals with
I(tobs < T ∗ik ≤ t′) = 1 as cases and individuals with I(tobs < T ∗ik ≤ t′) = 0 as controls.
In absence of any censoring in data (i.e., if the event in interest is observed for
every individual), the sensitivity and specificity defined in the Equations (2.27) and
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(2.28) can be estimated using the predicted failure probabilities for cases and controls,
respectively.
To deal with the censored event times, Li, Greene, and Hu (2018) proposed
alternative definitions of sensitivity and specificity based on the predictive distribution
of the censored event times as
Sensitivity : P̂r [πik(t′|tobs) > c |T ∗ik > tobs, I(tobs < T ∗ik ≤ t′) = 1]
=
∑n
i=1 Φ̂i(t, t′) I(πik(t′|tobs) > c)∑n
i=1 Φ̂i(t, t′)
, (2.29)












where, the weights Φ̂i(t, t′) are introduced to account for the censored event times
and are defined in the following. It is important to note that the individuals that
experienced the event before time tobs, i.e., Tik < tobs do not have any contribution
while computing the individual weights.
Φ̂i(t, t′) = I(tobs < Tik ≤ t′) δik+
I(tobs < Tik ≤ t′) (1− δik)Pr [T ∗ik < t′ |T ∗ik > tobs, π̂ik(t′|tobs)]
= I(tobs < Tik ≤ t′) δik+




ik ≥ t′ | π̂ik(t′|tobs)]
Pr [T ∗ik ≥ Tik | π̂ik(t′|tobs)]
]
, (2.31)
where, the conditional survival distributions, Pr [T ∗ik ≥ τ | π̂ik(t′|tobs)] (τ can be either
t′ or Tik) in Equation (2.31) can be estimated using a kernel-weighted Kaplan-Meier
method with a specified bandwidth b (Li, Greene, and Hu 2018) as







i′ 6=iKb [π̂i′k(t′|tobs), π̂ik(t′|tobs)] I(Ti′k = τ) δi′k∑




where, Ωk (k = 1, 2, . . . , K) denotes the set of distinct event times (i.e., Tik’s with
δik = 1), and Kb is the kernel function with bandwidth b. We use a uniform kernel
in this study. Li, Greene, and Hu (2018) demonstrated through numerical study
and theoretical arguments that the estimates are insensitive to misspecification of
kernel bandwidth. The time-dependent ROC curve and the AUC for the terminal
time-to-event can also be obtained in a similar way described above.
Using the estimated sensitivity and specificity values for all possible cut points
c ∈ (0, 1), we can construct the time-dependent ROC curve by plotting the sensitivity
against 1 - specificity and can obtain the corresponding AUC for the time horizon (t, t′]
using any standard method of numerical integration (e.g., Simpson’s rule, Trapezoidal
rule, etc.). The AUC can be interpreted very easily as a concordance index. The value
of AUC can range from 0 to 1 with AUC = 0 meaning no discriminatory power from
model predictions, AUC = 0.5 implies nothing better than a random guess, and AUC
= 1 indicates perfect discrimination.
2.5.2 Dynamic Brier Score
The concept of using dynamic Brier score (DBS) was introduced for measuring predic-
tion error in survival analyses (Gerds and Schumacher 2007; Gerds and Schumacher
2006) and later was extended and used in the context of joint models (Sène et al. 2016;
Proust-Lima et al. 2014; Schoop, Schumacher, and Graf 2011; Proust-Lima and Taylor
2009; Henderson, Diggle, and Dobson 2002). For kth (k = 1, 2, . . . , K) non-terminal
time-to-event, the dynamic expected BS can be defined as
E
[
{∆ik(t′ | tobs)− πik(t′ | tobs)}2
]
, (2.33)
where, ∆i(t′ | tobs) denotes the observed status of the event in interest for the specific
time horizon (t, t′] and takes value 1 if the individual i experience the kth non-terminal










{∆ik(t′ | tobs)− πik(t′ | tobs)}2
]
, (2.34)
where, Nktobs is the number of individuals at risk at time tobs for the kth non-terminal









where, the notation Ŝ0k(.) denotes the Kaplan-Meier estimates of survival probabilities
(Sène et al. 2016). One can obtain the DBS estimates for the terminal time-to-event
in the similar manner. The value of DBS presents an account of bias in the predicted
outcomes, and a lower BS value implies higher predictive accuracy for the estimated
model. While a DBS = 0 value indicates perfect predictions, DBS = 0.25 implies
nothing better than random guesses.
2.6 Simulation Study
To investigate the performances of the proposed model, parameter estimation, and
dynamic prediction algorithm, we have conducted statistical simulation studies. We
generated 250 datasets with n = 400 individuals in each. For each simulated dataset,
we generated data on M = 2 continuous longitudinally observed outcomes (Yi1 and
Yi2), event times for K = 2 non-terminal, and a terminal time-to-events. For all
individuals, we considered the maximum follow-up time Ci = 24, after which the
individuals were subject to be non-informatively right-censored. The follow-up for
individuals can also end before the maximum follow-up time if they experience the
terminal time-to-event.
For each individual i in a simulated sample, the longitudinal outcomes observations
are generated at time points t = tij = (0, 3, 6, 9, 12, 15, 18, 21, 24). The observations
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on latent trait Γi(t), the two continuous longitudinal outcomes (Yi1, Yi2), the two non-
terminal event times (Ti1 and Ti2), and the terminal event times (Ti) were generated
as
Γi(t) = β0 + β1Xi1 + β2t+ αi0 + αi1t, (2.36)
Yi1(t) = ϕ1 + Γi(t)ψ1 + ε1(t), (2.37)
Yi2(t) = ϕ2 + Γi(t)ψ2 + ε2(t), (2.38)
λi1(t) = λ01 exp [γ11Xi1 + ϑ1Γi(t) + ωi1] , (2.39)
λi2(t) = λ0k exp [γ21Xi1 + ϑ2Γi(t) + ωi2] , (2.40)
λi(t) = λ0 exp [γ1Xi1 + ϑΓi(t) + ξ1 ωi1 + ξ2 ωi2] , (2.41)
where, X1 is considered to be a dichotomous baseline covariate and generated from a
binomial distribution with success probability 0.50. The regression parameters in latent
trait model in the Equation (2.36) was set as (β0, β1, β2) = (2.20,−1.30, 0.75) and the
two random effects were generated from a bivariate normal distribution with standard
deviations and correlation parameters set to (σα0 , σα1 , ρα) = (0.45, 0.65, 0.50). The re-
gression parameters to generate the two continuous longitudinal outcomes, in the Equa-
tions (2.37) and (2.38), were set as (ϕ1, ϕ2) = (3.50, 5.00) and (ψ1, ψ2) = (2.70, 1.80).
We generated the longitudinal outcomes measurement errors from bivariate normal dis-
tribution with the standard deviations and correlation, (σε1 , σε2 , ρε) = (2.60, 1.90, 0.70).
The covariate (X1) effects and the latent trait effects on the two non-terminal and
the terminal time-to-events, in Equations (2.39), (2.40), and (2.41), were set as
(γ11, γ21, γ1) = (−0.40,−0.55,−0.70) and (ϑ1, ϑ2, ϑ) = (0.35, 0.45, 0.50) respectively.
We generated the non-terminal event frailties from bivariate normal distribution with
standard deviations and correlation parameters as (σω1 , σω2 , ρω) = (0.50, 0.40, 0.25)
and their effects on the terminal event risk were set to (ξ1, ξ2) = (0.25, 0.30). For
simplicity, we assumed the baseline hazards for both the non-terminal and terminal
time-to-events to be constant in this simulation study and were set as (λ01, λ02, λ0) =
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(0.30, 0.25, 0.15). For each simulated data set, we randomly selected 75% (n = 300)
individuals to use as the training dataset for estimating the model parameters, and we
used the remaining 25% (n = 100) individuals as the test data for validation purposes.
Table 2.1: Parameter estimation performance of the proposed model
using simulated training data.
Parameter True Value Estimate Bias SE CP RMSE
Latent Trait (Γ)
β0 2.20 2.158 -0.042 0.241 0.947 0.244
β1 -1.30 -1.329 -0.029 0.178 0.957 0.180
β2 0.75 0.735 -0.015 0.115 0.950 0.116
σα0 0.45 0.461 0.011 0.146 0.957 0.147
σα1 0.65 0.658 0.008 0.194 0.970 0.194
ρα 0.50 0.510 0.010 0.210 0.960 0.210
First Longitudinal Outcome (Y1)
ϕ1 3.50 3.533 0.033 0.356 0.963 0.357
ψ1 2.70 2.721 0.021 0.274 0.957 0.274
σε1 2.60 2.633 0.033 0.250 0.957 0.252
ρε 0.70 0.727 0.027 0.124 0.953 0.127
Second Longitudinal Outcome (Y2)
ϕ2 5.00 5.070 0.070 0.411 0.937 0.416
ψ2 1.80 1.804 0.004 0.186 0.940 0.186
σε2 1.90 1.895 -0.005 0.186 0.950 0.185
ρε 0.70 0.727 0.027 0.124 0.953 0.127
First Non-terminal Event (T1)
γ11 -0.40 -0.395 0.005 0.093 0.953 0.093
ϑ1 0.35 0.362 0.012 0.115 0.957 0.115
σω1 0.50 0.491 -0.009 0.161 0.953 0.160
ρω 0.25 0.258 0.008 0.103 0.950 0.103
Second Non-terminal Event (T2)
γ21 -0.55 -0.551 -0.001 0.100 0.957 0.100
ϑ2 0.45 0.466 0.016 0.122 0.940 0.123
σω2 0.40 0.395 -0.005 0.131 0.967 0.131
ρω 0.25 0.258 0.008 0.103 0.950 0.103
Terminal Event (T )
γ1 -0.70 -0.690 0.010 0.144 0.950 0.144
ϑ 0.50 0.517 0.017 0.097 0.937 0.099
ξ1 0.25 0.249 -0.001 0.033 0.960 0.033
ξ2 0.30 0.297 -0.003 0.052 0.950 0.052
SE = Standard Error; CP = Coverage Probability; RMSE = Root
Mean Square Error.
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Table 2.1 presents the estimated bias, standard error (SE), coverage probability
(CP), and root mean square error (RMSE) of the estimates of individual model
parameters using the simulated datasets. The bias was computed as the difference
in average of posterior means and true parameter values, SE was obtained as the
standard deviation of posterior means, and CP represents the true parameter coverage
probability of the 95% equal tail credible intervals (CrI). The results presented in Table
2.1 show that the estimates from the proposed model based on simulated training
data were obtained with small biases and RMSE. Their coverage probabilities as well
were very close to the nominal level, which is 0.95.
Table 2.2: The estimated time-dependent areas under ROC curves (AUC) and dynamic
Brier scores (DBS) for predictions of non-terminal and terminal time-to-events at time
t′ based on observation history at time tobs for individuals in simulated test datasets.
First Non-terminal Event Second Non-terminal Event Terminal Event
tobs t
′ AUC DBS AUC DBS AUC DBS
0 3 0.856 0.044 0.847 0.042 0.841 0.046
6 0.853 0.047 0.847 0.044 0.838 0.047
12 0.849 0.052 0.841 0.047 0.835 0.050
18 0.840 0.052 0.836 0.048 0.829 0.053
24 0.837 0.054 0.834 0.054 0.825 0.055
3 6 0.860 0.039 0.858 0.044 0.849 0.043
12 0.860 0.041 0.841 0.044 0.840 0.044
18 0.858 0.044 0.834 0.045 0.836 0.045
24 0.843 0.045 0.829 0.048 0.830 0.046
6 12 0.885 0.039 0.877 0.039 0.863 0.040
18 0.886 0.041 0.870 0.039 0.854 0.040
24 0.875 0.042 0.863 0.042 0.832 0.042
12 18 0.912 0.038 0.898 0.039 0.893 0.039
24 0.891 0.039 0.886 0.039 0.888 0.041
18 24 0.915 0.037 0.908 0.036 0.899 0.038
We further have used the estimated joint model for each simulated training
sample and made predictions on the probabilities of events for the non-terminal events,
π̂ιk(t′|tobs), and the terminal event, π̂ι(t′|tobs), at time t for the individuals in validation
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dataset using their observation histories until time tobs. We then have computed the
time-dependent area under ROC curve (AUC) and dynamic Brier score (DBS) for
each set of t and tobs and presented in Table 2.2. We observed that the AUC values
were high (> 0.80), indicating good discriminatory performance, and the smaller (<
0.06) DBS values also suggested low prediction error. In general, both the AUC and
DBS measures showed trends to improve as the amount of observed data used in
prediction increases and showed a trend of drops in performance as the prediction
time point (t) goes further from the last observation time point (tobs).
2.7 Application
In the United States (US), more than 1.2 million people are living with HIV infection
(CDC 2014), and more than 40,000 new HIV infections are being added to that every
year (Hall et al. 2008; Prejean et al. 2011). Given the developments of effective
antiretroviral therapy (ART), more HIV infected patients now surviving to older ages
like other non-infected people. Studies reported based on the data from patients in
the US and Canada that the life expectancy of a 20 years old HIV infected patient has
been extended from 39 years in 1996 to 73 years in 2011 (Samji et al. 2013; Marcus
et al. 2016). With the increase in life expectancy, non-HIV/AIDS opportunistic
disease conditions have been very instrumental in determining the comorbidity and
mortality among HIV infected patients (Antiretroviral Therapy Cohort Collaboration
2010; D: A: D Study Group et al. 2010) in clinical care. HIV patients are now at
higher risk of developing non-HIV/AIDS and age-related complications, including
cardiovascular disease, renal disease, cancer, diabetes, hypertension (Önen et al. 2010).
In addition to age-related factors, some of these conditions have been linked to the
use of antiretroviral drugs (D: A: D Study Group 2007; Wand et al. 2007).
When accounting for the deaths among HIV infected patients, studies have reported
that more than 50% of such deaths can be attributed to non-HIV/AIDS health
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conditions (Antiretroviral Therapy Cohort Collaboration 2010; D: A: D Study Group
et al. 2010). Given the rise in incidence of comorbidities among the HIV patients and
the increasing death toll they claim, it is necessary to understand the associations
between the HIV disease condition, comorbidity risks, and mortality. Towards such
effort, we present an application of the proposed joint model in this chapter to analyze
a set of statewide data collected from HIV/AIDS patients in South Carolina (SC).
SC, a rural state in the southern US, consistently ranks as one of the top in nation
for it’s high annual HIV/AIDS incidence rate (Chakraborty et al. 2017) and the rates
comorbidities and associated morality among the HIV patients also have been reported
to be high (Cima et al. 2016). The data used in this application were extracted from
the South Carolina (SC) enhanced HIV/AIDS Reporting System (eHARS) surveillance
database maintained by the South Carolina Department of Health and Environmental
Control (SCDHEC). The analysis sample consisted of a selected group of SC residents
aged 13 years or older and were diagnosed with HIV infection between 1 January,
2004 and 31 December, 2013.
We used the repeated measures on patient CD4 cell counts (cell/mm3) and viral
loads (VL, copies/mL) as the longitudinal disease biomarkers. The measures on CD4
cell counts were used as a continuous biomarker, while the VL measures were used
to form a dichotomous biomarker with categories: detectable and undetectable VL.
The detectable and undetectable VL categories were defined as VL ≥ 200 and VL
< 200 copies/mL, respectively. Due to the skewed distribution of observed CD4 cell
counts, we used a square root transformation before using them in this application.
Along with the death defined as the terminal time-to-event, we considered modeling
three comorbidities as the non-terminal time-to-events in this application. For the
patients in the sample, we used the International Statistical Classification of Disease
9th Revision (ICD-9) and identified all the comorbidities described in Elixhauser
comorbidities coding algorithm in administrative data (Quan et al. 2005) and selected
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highly incident three comorbid conditions, namely cardiac arrhythmias (CA), fluid
and electrolyte disorders (FED), and liver disease to model in this application.
For the semiparametric latent trait longitudinal submodel, we considered an unob-
served health condition of the patients, which is assumed to be positively associated
with the longitudinally observed CD4 cell counts and undetectable VL. The assumed
latent health condition can be thought of as a measure of a patient’s physical well-
being, which is the opposite of disease severity. The corresponding model equations
for the latent health condition and the longitudinal biomarkers can be expressed as√
CD4 Cell Counti(t) = ϕ1 + Latent Health Conditioni(t)ψ1 + ε1i(t),
logit [Pr {(VL(t) = Undetectable)}] = ϕ2 + Latent Health Conditioni(t)ψ2,
where, the parameters ψ1 and ψ2 are assumed to be positive. A higher value of
underlying health condition reflects better health condition (representing higher CD4
cell count and a higher probability of undetectable VL) of the patients.
Out of the 5,169 adults (≥ 13 years old) patients diagnosed with HIV/AIDS in the
years between 2004 and 2013, we utilized data from 1,331 patients in this analysis. A
majority of the patients were excluded due to missing treatment information, CD4 cell
counts, and VL measurements. Patients were also excluded due to missing covariate
values. The characteristics of patients in the analysis sample are summarized and
presented in Table 2.3. The analysis sample was dominated by patients aged ≥ 30 years
(n = 875, 65.74%), patients with race/ethnicity other than White (n = 1084, 81.44%),
and patients who were urban resident at their time of HIV diagnosis (n = 899, 67.54%).
The proportion of female patients (n = 707, 53.12%) was slightly higher than that
of male patients, 57.40% (n = 764) patients were identified to be exposed to HIV
risk other than being heterosexual. The patients with other risk exposures include
injecting drug users (IDU) and men having sex with men (MSM). More than one-third
of the patients (n = 557, 41.85%) in the analysis sample developed AIDS at the time
of their diagnosis while the rest were diagnosed with HIV infection only, and a similar
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proportion of the patients (n = 547, 41.10%) started their antiretroviral therapy (ART)
with single-tablet regimen (STR). Among the considered comorbid conditions, 10.89%
(n = 145), 9.17% (n = 122), and 7.59% (n = 101) of the patients were diagnosed
with fluid and electrolyte Disorders (FED), cardiac arrhythmias (CA), liver Disease
respectively during the follow-up time period. A total of 159 (11.95%) patients died
during the time.
Table 2.3: Characteristics of South Carolina HIV/AIDS patients, adult, diagnosed
between 2004-2013, and included in the analysis sample (n = 1, 331).
Characteristics Frequency (%) Characteristics Frequency (%)
Age at Diagnosis Diagnosis Type
< 30 years 456 (34.26) HIV and AIDS 557 (41.85)
≥ 30 years 875 (65.74) HIV Only 774 (58.15)
Gender Starting ART
Male 624 (46.88) STR 547 (41.10)





Urban 899 (67.54) Comorbidity and Mortality Frequency (%)
Rural 432 (32.46) Fluid and Electrolyte Disorders 145 (10.89)
Risk Group Cardiac Arrhythmias 122 (9.166)
Heterosexual 567 (42.60) Liver Disease 101 (7.588)
Others2 764 (57.40) Death 159 (11.95)
1Black and Other Races; 2Injecting Drug Users (IDU), Men having Sex with Men
(MSM); ART = Antiretroviral Treatment; STR = Single-tablet Regimen; MTR =
Multiple-tablet Regimen; CrI = Credible Interval.
Estimated joint model parameters (posterior means) and 95% equal tails credible
intervals (CrI) are presented in Table 2.4 (longitudinal submodel parameters for
latent trait), Table 2.5 (longitudinal submodel parameters for longitudinal outcomes),
and Table 2.6, 2.7 (time-to-events submodel parameters). As seen in Table 2.5, the
latent health condition (physical well-being) was positively associated with both
the longitudinal disease biomarkers, the CD4 cell counts, and the probability of
undetectable VL.
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Table 2.4: Estimated longitudinal submodel (latent trait model) parameters for the
joint model of disease biomarkers, comorbidities, and death using the data on selected
(n = 1, 331) South Carolina HIV/AIDS patients diagnosed in the period 2004-2013.
Characteristics Latent Health Condition
Coefficient (95% CrI)
Fixed Effects
Intercept 20.2 (19.4, 21.0)
Years from Diagnosis 0.73 (0.63, 0.83)
Age at Diagnosis
≥ 30 years 1.16 (0.32, 1.89)
< 30 years Ref
Gender
Male -2.66 (-3.25, -1.99)
Female Ref
Race/Ethnicity
White 1.21 (0.27, 2.03)
Others1 Ref
Residence at Diagnosis
Urban -0.18 (-0.71, 0.40)
Rural Ref
Risk Group
Heterosexual -0.43 (-0.83, 0.57)
Others2 Ref
Diagnosis Type
HIV and AIDS -4.53 (-5.06, -3.97)
HIV Only Ref
Starting ART




Years from Diagnosis 1.50
Random Effects Correlation -0.41
VL = Viral load; 1Black and other races; 2Injecting Drug Users (IDU), Men having
Sex with Men (MSM); ART = Antiretroviral Treatment; STR = Single-tablet
Regimen; MTR = Multiple-tablet Regimen; OR = Odds Ratio; CrI = Credible
Interval; SD = Standard Deviation.
The dependence association of the latent health condition on patient characteristics
(2.4) indicated that the duration since diagnosis, age, sex, race, and type of HIV
diagnosis were the statistically significant attributes to determine patients’ well-being.
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Longer duration since diagnosis, being young (< 30 years), and White race were found
to improve patients’ latent health condition statistically significantly. On the other
hand, the male gender, and HIV diagnosis after developing AIDS were significantly
negatively associated with the latent health condition.
Table 2.5: Estimated longitudinal submodel (mixed effects model) parameters for the
joint model of disease biomarkers, comorbidities, and death using the data on selected




CD4 Cell Count Undetectable VL
Coefficient (95% CrI) OR (95% CrI)
Intercept 17.5 (17.1, 17.9) 0.07 (0.05, 0.10)
Latent Health Condition 2.53 (2.38, 2.69) 1.27 (1.25, 1.30)
Measurement Error (SD) 2.78
While examining the parameter estimates from the non-terminal time-to-event
submodels in Table 2.6 and the terminal time-to-event in Table 2.7, we found that
patient age, gender, race, HIV risk exposure, and starting ART type were the patient
characteristics to statistically significantly influence the patients’ risks of developing
the comorbid conditions and death. However, the patient characteristics influencing
the time-to-events varied by the event types. The younger (< 30 years) and the
White patients observed significantly reduced risk of developing fluid and electrolyte
disorder (FED) compared to their counterparts. In contrast, heterosexual HIV patients
were at significantly higher risk of developing FED compared to others, including
injecting drug users (IDU) and men having sex with men (MSM). For the comorbid
conditions of cardiac arrhythmias (CA) and liver disease, we found that being young,
being heterosexual, and receiving STR helped the patients to reduce the risk of both
statistically significantly. For the terminal event of death, the patient age (being
younger) was the only factor among those used to influence significantly (reduce) their
risk of death directly.
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Table 2.6: Estimated time-to-events submodel (non-terminal events) parameters for
the joint model of disease biomarkers, comorbidities, and death using the data on
selected (n = 1, 331) South Carolina HIV/AIDS patients diagnosed in the period
2004-2013.
Non-terminal Comorbidities
Characteristics FED CA Liver Disease
HR (95% CrI) HR (95% CrI) HR (95% CrI)
Age at Diagnosis
≥ 30 years 0.71 (0.38, 0.81) 0.80 (0.46, 1.25) 0.44 (0.23, 0.56)
< 30 years Ref Ref Ref
Gender
Male 0.96 (0.70, 1.03) 0.71 (0.41, 1.21) 1.06 (0.61, 1.28)
Female Ref Ref Ref
Race/Ethnicity
White 0.76 (0.62, 0.73) 1.42 (0.83, 2.29) 1.53 (0.87, 1.89)
Others1 Ref Ref Ref
Residence at Diagnosis
Urban 1.01 (0.63, 1.12) 1.07 (0.67, 1.76) 1.68 (0.98, 1.98)
Rural Ref Ref Ref
Risk Group
Heterosexual 1.38 (0.99, 1.42) 0.53 (0.32, 0.91) 0.63 (0.34, 0.74)
Others2 Ref Ref Ref
Diagnosis Type
HIV and AIDS 1.02 (0.50, 1.20) 1.29 (0.77, 2.11) 0.84 (0.47, 1.02)
HIV Only Ref Ref Ref
Starting ART
STR 0.97 (0.61, 1.03) 0.85 (0.52, 1.38) 0.74 (0.45, 0.87)
MTR Ref Ref Ref
Comorbidity Frailties
Fluid and Electrolyte Disorder (FED)
Cardiac Arrhythmias (CA)
Liver Disease
Latent Health Condition 0.83 (0.79, 0.86) 0.94 (0.89, 0.99) 0.96 (0.92, 0.98)
Comorbidity Frailty (SD) 0.66 0.53 0.47
Comorbidity Correlation
Fluid and Electrolyte Disorder (FED) 0.20 0.14
Cardiac Arrhythmias (CA) 0.20 0.14
Liver Disease 0.14 0.14
FED = Fluid and Electrolyte Disorder; CA = Cardiac Arrythmias; 1Black and other
races; 2Injecting Drug Users (IDU), Men having Sex with Men (MSM); ART =
Antiretroviral Treatment; STR = Single-tablet Regimen; MTR = Multiple-tablet
Regimen; HR = Hazard Ratio; CrI = Credible Interval; SD = Standard Deviation.
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Table 2.7: Estimated time-to-events submodel (terminal event) parameters for the
joint model of disease biomarkers, comorbidities, and death using the data on selected




≥ 30 years 0.46 (0.30, 0.69)
< 30 years Ref
Gender
Male 1.48 (1.00, 2.10)
Female Ref
Race/Ethnicity
White 1.08 (0.70, 1.73)
Others1 Ref
Residence at Diagnosis
Urban 0.54 (0.39, 0.74)
Rural Ref
Risk Group
Heterosexual 0.81 (0.55, 1.15)
Others2 Ref
Diagnosis Type
HIV and AIDS 1.15 (0.82, 1.64)
HIV Only Ref
Starting ART
STR 0.74 (0.48, 1.04)
MTR Ref
Comorbidity Frailties
Fluid and Electrolyte Disorder (FED) 9.27 (4.56, 20.6)
Cardiac Arrhythmias (CA)
Liver Disease 1.64 (0.20, 12.3)
Latent Health Condition 0.87 (0.84, 0.91)
FED = Fluid and Electrolyte Disorder; CA = Cardiac Arrythmias; 1Black and other
races; 2Injecting Drug Users (IDU), Men having Sex with Men (MSM); ART =
Antiretroviral Treatment; STR = Single-tablet Regimen; MTR = Multiple-tablet
Regimen; HR = Hazard Ratio; CrI = Credible Interval; SD = Standard Deviation.
The latent health condition representing the longitudinal measures on disease
biomarkers and indicating patients’ physical well-being was found to significantly
reduce the risk of all three comorbidities as well as the risk of death. Risks of all three
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comorbidities were positively correlated, as was evident from positive correlations be-
tween the corresponding frailties. Two of the three comorbidities, cardiac arrhythmias,
and fluid and electrolyte disorder, were found to significantly elevate the risk of death
among the patients. Having a comorbid condition of liver disease increased the risk of
death but could not be considered as statistically significant.
2.8 Discussion
In most clinical studies of patients with chronic disease, it is often the case that data
are being longitudinally collected on multiple disease biomarkers as well as multiple
time-to-event such as the opportunistic comorbidities. The standard univariate joint
models and extensions are not capable of providing the benefits of analyzing such
correlated multivariate data in a unified framework.
Despite the practical needs, the joint models for multivariate longitudinal outcomes
and multiple time-to-event have remained understudied for long. For example, Liu
and Huang (2009) used a joint modeling framework to analyze the risks comorbidities
among the HIV/AIDS patients in the presence of a terminal event defined by death.
They longitudinally modeled repeated measures on CD4 cell counts in their analysis.
However, while modeling the comorbidity risks, Liu and Huang (2009) treated the
incidence of multiple comorbidities as a single recurrent time-to-event. Apparently,
this was not an ideal solution, as the different comorbidities might have different risk
profiles and might have been influenced differently by the patient characteristics.
With a specific interest in the non-recurrent unordered time-to-events, this study
proposed a semiparametric latent trait shared parameter joint frailty model for ana-
lyzing multivariate longitudinal outcomes and multiple time-to-event while accounting
for the dependent censoring induced by the presence of a terminal event. It has been
reported that the developments of multivariate joint models are somewhat hindered
by the growing complexities and computational burden due to the increasing number
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of subject-specific parameters (Verbeke et al. 2014). To reduce such complexities, this
present study used a semiparametric latent trait approach to model the multivariate
longitudinal outcomes. The latent trait approach reduces the multivariate longitudinal
outcomes to a univariate latent trait and thus provides computational ease by elimi-
nating the necessity to consider subject-specific effects for each longitudinal outcomes.
The adopted approach of semiparametric latent trait modeling for the multivariate
longitudinal outcomes in our proposed model was inspired by the works of Huang et al.
(2001) where a latent variable model was used for multivariate responses, Dunson
(2007) that discusses Bayesian methods for latent trait modeling of longitudinal data
and following a recent works by He and Luo (2016) and Wang, Luo, and Li (2017)
where similar semiparametric latent variable models have been employed in joint
modeling settings for a single time-to-event under independent censoring assumption.
While the computational ease attained from reducing the dimension of longitudinal
outcomes through the use of latent trail approach greatly benefited the developments
presented in this study, these benefits came with a couple of trade-offs. Firstly, if
the main objective of an analysis lies in examining the direct covariate effects on
the longitudinal outcomes while accounting for the informative drop-outs due to
the time-to-events, the proposed model may not be the best choice to use. By the
structure of development, the proposed model only estimates the covariate effects
on the longitudinal outcomes indirectly through the assumed latent trait. Secondly,
application of the proposed model requires the balanced and simultaneous collection of
all the longitudinal outcomes at follow-up time points to facilitate the construction of
latent trait in model fitting. In an unbalanced case where the number of measurements
on a longitudinal outcome, as well as the data collection time points, may differ by
individuals and by the outcome type, the proposed model may not be applicable.
The other contribution this study made is outlining and implementing a joint model
dynamic prediction algorithm in a multivariate longitudinal outcome and multiple
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time-to-event problem in the presence of informative censoring from a terminal event.
The dynamic prediction algorithms in existing literature are mostly limited to joint
models of a single time-to-event.
Given the complexity of the proposed model, we have considered a fully Bayesian
approach of estimating the parameters and proposed a Bayesian MCMC approach
for making dynamic predictions. The estimation and dynamic prediction algorithms
performed satisfactorily, as were seen in the simulation study. An application of the
proposed model revealed covariate effects and important relationships between the
HIV/AIDS disease biomarkers, selected highly frequent comorbidities, and mortality
among the HIV/AIDS patients in SC.
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Chapter 3
Survival Function Estimation for Multiple
Sequential Time-to-Event
3.1 Introduction
In Chapter 2, we have presented an approach of jointly modeling multivariate longitu-
dinal outcomes and multiple unordered time-to-events in the presence of a terminal
event. Our proposed model seeks to fill a gap in the joint modeling literature and
offers a means to analyze a complex and correlated data structure with accounting
for all sources of correlations. When considering the nature of time-to-events, it is
not uncommon to have problems analyzing time-to-events of ordered type. In this
chapter and the next, we extend our interest to the analyses of ordered time-to-events.
Our eventual interest is to derive a joint model for multivariate longitudinal outcomes
and multiple ordered time-to-events, which will be presented in Chapter 4. In this
chapter, we discuss a problem of estimating survival functions for multiple ordered
time-to-events.
In many clinical studies, individuals may experience multiple time-to-event in the
follow-up period. The time-to-event data may be observed in an orderly fashion where
a specific event can only be observed if and only if an individual has experienced the
previous event(s). Such events can be referred to as sequential time-to-events as they
occur in a certain sequence. The sequential time-to-events of concern in a study can
be the recurrence of the same event or can be of different segments of a process, for
example, studying the viral load (VL) rebound among HIV/AIDS patients is a two
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segments process; transitioning from a detectable to suppressed VL condition and then
again returning back to the detectable VL condition. For sequential time-to-events
data, one may consider two possible time scales. First, the gap time, times between
the successive events; and second, the total time (also referred to as the calendar time)
measured from the study onset to the occurrence of respective events.
Estimation of the survival functions for the sequentially observed time-to-events
has been an interesting problem and been studied by many authors. Most studies
in the literature focused on studying the non-parametric analyses of the gap times
between sequential events. Some studies restricted the possible number of time-to-
events to be only two (e.g., Campbell 1981; Tsai, Leurgans, Crowley, et al. 1986;
Burke 1988; Lin and Ying 1993; Huang 2000; Akritas and Keilegom 2003; Uña-Álvarez
and Meira-Machado 2008) and described the bivariate joint distribution for gap
times. While others (e.g., Prentice and Cai 1992; Wang and Wells 1998; Lin, Sun,
and Ying 1999; Van Der Laan, Hubbard, and Robins 2002; Schaubel and Cai 2004;
Meira-Machado et al. 2009; Meira-Machado, Sestelo, and Gonçalves 2016) focused on
the conditional survival function of the gap times studied the cases of two or more
sequential time-to-events. Some authors (Lin, Sun, and Ying 1999; Schaubel and Cai
2004) argued that the study of marginal survival curves of sequential time-to-events
did not grow due to their problem with being non-identifiable under an assumption of
dependence between the consecutive event times.
While observing the data on multiple sequential time-to-events, one may assume
the successive event times to be independent. However, in many situations, within-
individual consecutive event times may not be independent. Lack of such independence
results in a form of dependent censoring sometimes referred to as ‘induced dependent
censoring’ (Wang and Wells 1998; Wang 1999; Lin, Sun, and Ying 1999; Huang 2000).
A successive event then becomes censored by a dependent variable related to the
previous event times. For instance, in a case of such dependence, a longer observation
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time for an event in the sequence may increase the probability of successive events
for being censored. Even though the overall follow-up time can be assumed to be
independent of censoring times, the gap times between successive events except the
first are all subject to dependent censoring. This makes the estimation of marginal
survival of the gap times nontrivial (Lin, Sun, and Ying 1999).
Given the non-identifiability of the marginal survival function of gap times, some
researchers focused on the meaningful non-parametric estimation of the conditional
survival function (Lin, Sun, and Ying 1999; Schaubel and Cai 2004). However, in
most instances, such estimators are either very complex or derived under certain
assumptions, both of which may restrict their real-life applications. For instance,
Wang and Wells (1998) used weighting by inverse of the probability of remaining
uncensored to adjust for induced censoring and had a very complicated covariance
structure. Lin, Sun, and Ying (1999) and Schaubel and Cai (2004) used similar
approach as in Wang and Wells (1998). Meira-Machado, Sestelo, and Gonçalves
(2016) assumed that a current event in the sequence is censored at the time of the
previous event been censored, and the censoring time is the same as the previous event.
However, in practice, an individual may not even be at risk for a current event without
experiencing the previous event, and we do not observe any partial or complete data
on the current event for this individual.
In this study, we relaxed the nature of dependence between the successive event
times and presented a straightforward non-parametric approach of estimating the
marginal survival function of the time-to-events on a total time scale. For data
where the independence between the successive event times can not be relaxed, we
discuss using a fully parametric multivariate log-normal model for estimating both
the marginal and conditional survival functions.
The rest of the chapter is organized as follows. Section 3.2 presents the non-
parametric and parametric methods of estimating the survival functions. The finite
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sample properties of the estimation methods are studied through statistical simulation
in section 3.3. An application of the methods is demonstrated in section 3.4, and the
final section 3.5 presents a discussion.
3.2 Methods
Let us consider that an individual in a follow-up period may experience K sequential
time-to-events at the true event times T ∗1 < T ∗2 < . . . < T ∗K−1 < T ∗K = T ∗, where T ∗ is
the true total time the individual needs to experience all the K events. We assume
that the event times are subject to univariate right censoring by C, which is assumed
to be independent of event times. For k > 1, let T̃ ∗k = T ∗k − T ∗k−1 denote the true gap
times between the (k − 1)th and kth sequential time-to-events. For k = 1 (first event
in sequence), the gap time equals the event time i.e., T̃ ∗1 = T ∗1 . Figure 3.1 presents an






























Figure 3.1: Diagram showing an example of data collected on multiple sequential
time-to-event.
Due to censoring, we do not observed the true survival times. Thus for an
individuals, instead of observing the true event times
(
T ∗1 , T
∗




K = T ∗
)
, we
observe (T1, T2, . . . , TK−1, TK = T, δ1, δ2, . . . , δK−1, δK), where Tk = min(T ∗k , C) and
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the event indicator to be δk = I (T ∗k ≤ C) ; k = 1, 2, . . . , K. T ∗k and C are the true
survival and censoring times, respectively as denoted above. Given the (k − 1)th
event is observed in the follow-up period, T̃k = Tk − Tk−1 denote the observed gap
times between the successive event times. It is to be noted that, a next event only
can be observed after observing the previous event. To clarify further, an individual i
can not be at risk for event k without observing the events 1, 2, . . . , (k − 1) where,
k = 1, 2, . . . , K.
In this study, we present two approaches of estimating the marginal and conditional
survival function of time-to-events occurring in a sequence. Let us define the marginal
and condition survival functions for kth time-to-event in a sequence of K events as
Sk(t) = Pr [T ∗k > t] and Sk
(
t̃
∣∣∣ t) = Pr [T̃ ∗k > t̃ ∣∣∣T ∗k−1 = t], where k = 1, 2, . . . , K, and
t, t̃ ∈ [0,∞], t̃ ≥ t. In the first approach, assuming possible independence between
the consecutive event times, we used a non-parametric maximum-likelihood estimator
of the marginal survival functions on a scale of total time. The second approach
presents a fully parametric maximum-likelihood method of estimating the marginal
and conditional. The marginal survival functions are estimated in total time scale
while estimating the conditional survival functions of the events are estimated in the
gap time scale. The parametric approach assumes a log-normal distribution for the
sequential event times.
3.2.1 Nonparametric Estimation
Let us assume independence between the sequential event times that is, the event time
for first event (T1) and the consecutive gap times
(
T̃2, T̃3, . . . , T̃K
)
are independent.
Let S̃k (.) denotes the survival function for kth time-to-event on a gap time scale, and
f̃k (.) = −dS̃k (.) denotes the gap time density function. To derive an estimator for
the marginal survival function for kth (k > 1) time-to-event in the sequence at any
time t ∈ [0,∞] denoted as Sk (t), let us express
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Sk (t) = 1− Fk (t) ,
= 1− Pr (T ∗k ≤ t) ,
= 1− Pr
(



















































































where, the expression (3.1) follows from the convolution concept to derive the distri-



























for k = 1, 2, . . . , K and i = 1, 2, . . . , n denotes observations
from the joint distribution of
(




. Also let nk to be the number of individuals
at risk for the kth time-to-event in the sequence where, n1 = n, as the entire
sample of n individuals are subject to be at risk of experiencing the first event and
n1 ≥ n2 ≥ . . . ≥ nk. Say, (Rk; k = 1, 2, . . . , K) represent the set of individuals at risk
for the kth time-to-event. As the censoring times are assumed to be independent of the
event times, the non-parametric likelihood using the observed data from individuals
at risk for the first time-to-event in the sequence can be written as
L1 (S1;Ti1, δi1 : i ∈ R1) =
∏
i∈R1
[S1 (Ti1)]1−δi1 [f1 (Ti1)]δi1 , (3.3)
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where, f1(.) denotes the density function of the first event times (T ∗1 ) and again
the risk set R1 include all individuals in the sample. Similarly, for the kth (k > 1)
time-to-event in the sequence, non-parametric likelihood can be formed using the
observed gap time data since occurrence of (k− 1)th event for individuals those are in



















where, as defined before, f̃k (.) = −dS̃k (.) denotes the density function for the kth
event gap times. Under the assumed independence between the successive event times,



























































S̃k; T̃ik, δik : i ∈ Rk
)
(3.6)
Since the event specific log-likelihoods contributions, L1 (S1;Ti1, δi1 : i ∈ R1) and
L̃k
(
S̃k; T̃ik, δik : i ∈ Rk
)





can be maximized by maximizing the event specific log-
likelihoods separately. Assuming discrete failure times, for the first time-to-event in
the sequence, let us consider that
(
τ1(1), τ1(2), . . . , τ1(m1)
)
denotes the observed ordered
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denotes the number of failures and censored indi-
viduals at time τ1(j) (j = 1, 2, . . . ,m1). Then we can express the log-likelihood contribu-
tion of the first time-to-event, L1(.), as a function of
(
τ1(j), d1(j), c1(j); j = 1, 2, . . . ,m1
)
as in following.
L1 (S1;Ti1, δi1 : i ∈ R1) =
∑
i∈R1






















S1; τ1(.), d1(.), c1(.)
)
(3.7)
This way, the maximization of L1(.) becomes a problem of obtaining maximum
likelihood estimates (MLE) of m1 parameters representing the values of survival
function at the distinct failure times. The log-likelihood contribution of the kth
(k = 2, 3, . . . , K) event in the sequence can also be expressed as in following for
observed ordered distinct failure gap times
(






denoting the number of failures and censored individuals at τ̃k(j) (j = 1, 2, . . . ,mk)
L̃k
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S̃k; τ̃k(.), dk(.), ck(.)
)
(3.8)




denotes the discrete hazard function at the
distinct ordered failure time τ1(j) (j = 1, 2, . . . ,m1) for the first time-to-event in





T ∗1 = τ1(j)
]
, for j = 1
Pr
[
T ∗1 = τ1(j)
∣∣∣T ∗1 > τ1(j−1)] , for j > 1
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The survival function for the first time-to-event, S1(t), for t ≥ τ1(j) can then be
expressed in terms of the hazard functions λ (.) as in equation (3.9), and further, the
corresponding log-likelihood contribution L1 (S1;Ti1, δi1 : i ∈ R1) can be rewritten as
in equation (3.10).
S1(t) = Pr [T ∗1 > t] = Pr
[




T ∗1 > τ1(j)
∣∣∣T ∗1 > τ1(j−1)]× Pr [T ∗1 > τ1(j−1)]
= Pr
[
T ∗1 > τ1(j)
∣∣∣T ∗1 > τ1(j−1)]×
Pr
[
T ∗1 > τ1(j−1)




















L1 (S1;Ti1, δi1 : i ∈ R1) =
∑
i∈R1


















































denotes the number of individuals at risk for the




= 0 yields an MLE of λ1(j) as
λ̂1(j) = d1(j)/n1(j) for j = 1, 2, . . .m1. Thus a non-parametric maximum likelihood
estimator (NPMLE) for S1(t) can be obtained by plugging in the MLEs λ̂1(j) in the









which is the nothing but the Kaplan-Meier (Kaplan and Meier 1958) estimator of S1(t).




under independence assumption, we can obtain the NPMLE of the kth event’s gap












where, ˆ̃λk(j) = dk(j)/nk(j) is the MLE of hazard function for kth event, λ̃k(j), at the






denotes the number of individuals at risk for the kth time-to-event at the gap time
τ̃k(j). Note that the NPMLE estimator ˆ̃Sk(t̃) is also an Kaplan-Meier estimator based









an NPMLE of the marginal survival function for the kth time-to-event, Sk(t), can be
obtained using the equation (3.2). For discrete distinct ordered failure gap times for
the kth event
(
τ̃k(1), τ̃k(1), . . . , τ̃k(mk)
)







































The NPMLE of Sk(t) then can be obtained as in following by using the NPMLEs of







) [ ˆ̃Sk (τ̃k(j−1))− ˆ̃Sk (τ̃k(j))] (3.14)
3.2.2 Parametric Estimation
In derivation of the non-parametric maximum likelihood estimator of the marginal
survival functions for sequential time-to-events in section 3.2.1, we assumed indepen-
dence between the consecutive event times. That is, the event time for the first event
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(T1) in the sequence and the consecutive gap times
(
T̃2, T̃3, . . . , T̃K
)
were assumed
to be independent. However, in practice, these event times may not be indepen-
dent. If an individual is followed for a fixed duration of time, longer event times
for earlier events in the sequence may increase the chance of being censored for any
following event. And the gap times for the following events become censored by a
dependent variable related to event times for previous events, which again violates
the assumption of non-informative censoring. A fully parametric model can relax
the independence assumption and adjust the analyses to account for the dependence
in question. In this section, we present a fully parametric method of estimating the
marginal and conditional survival functions of the sequential time-to-events using a
multivariate log-normal model. Let us consider that the true sequential event times(
T ∗1 , T̃
∗




are multivariate log-normally distributed and the log-transformed
event times (Y1, Y2, . . . , YK) =
(
log T ∗1 , log T̃ ∗2 , . . . , log T̃ ∗K
)
jointly follows a multivari-
ate normal distribution with density function









−12 (y − µ)
′ Σ−1 (y − µ)
]
, (3.15)
where, y = (y1, y2, . . . , yK) is a vector of observed values for (Y1, Y2, . . . , YK), µ =
(µ1, µ2, . . . , µK), and Σ respectively denotes the vector of means and the covariance
matrix of dimension K ×K. If (σ21, σ22, . . . , σ2K) denote variances of (Y1, Y2, . . . , YK),
the marginal distributions for Y1, Y2, . . . , YK are univariate normal as Yk ∼ N(µk, σ2k),
for k = 1, 2, . . . , K. The conditional distributions of Y ’s are also normal, for instance,
the conditional distribution of Yk |Yk−1, Yk−2, . . . , Y1 is univariate normal with
mean = µk + Σl Σ−1r (yr − µr) , and
variance = σ21 −Σl Σ−1r Σ′l,
where, Σl = [σkσk−1, σkσk−2, . . . , σkσ1] is a 1 × (k − 1) matrix of the covariances of
(Yk−1, Yk−2, . . . , Y1) with Yk. µr and Σr respectively denotes the mean vector and
covariance matrix of (Yk−1, Yk−2, . . . , Y1) while yr is vector of observed values.
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Given the known marginal and conditional normal distributions of Yi’s, the re-
spective log-normal marginal and conditional distributions for the original event
times
(
T ∗1 , T̃
∗








for k = 1, 2, . . . , K and i = 1, 2, . . . , n, denoting the observations from the joint
distribution of
(
























∣∣∣ T̃i(k−1), . . . , T̃i1)1−δik ]], (3.16)
where, θ contains the associated mean and variance-covariance parameters. S1(.)
and S̃k(.) are denoting the marginal and conditional survival functions for event
times T1 and T̃k respectively for k = 1, 2, . . . , K. The survival functions can be
estimated by using maximum likelihood estimates of parameters in θ by maximizing


















∣∣∣ T̃i(k−1), . . . , T̃i1)+
(1− δik) log S̃k
(
T̃ik
∣∣∣ T̃i(k−1), . . . , T̃i1) ] (3.17)
3.3 Simulation Studies
We have performed simulation studies to evaluate the finite sample performances
of both the non-parametric and parametric estimation methods we discussed. For
simplicity, we considered cases K = 2 in the simulation studies. To study the finite
sample performance of the non-parametric MLE of the marginal survival function,
we generated the true event times for the first time-to-event (T ∗1 ) from a Weibull
distribution with shape and scale parameter values 4 and 10 respectively. The true gap
times between first and second time-to-event
(




an exponential distribution with mean 14.28. The censoring times C were generated
from an exponential distribution as well. We performed the simulation studies for
four different setups obtained by the combinations of two sample sizes 30, 100, and
two censoring rates 10%, 30%. The mean of exponential distribution while generating
censoring times were determined to ensure censoring rates 10% and 30%. For each
setup, 1,000 sets of data were generated. For each generated dataset, the NPMLEs
of marginal survival curves, S1(t), and S2(t), for total times were estimated and
median of 1,000 curves was taken to get point-wise median NPMLEs. We plotted the
estimated marginal survival curves overplayed with the true curves for comparisons.
In the case of parametric log-normal estimation method, we generated 1,000 samples
for each simulation setup of sizes (30, 100) and censoring rates (10%, 30%). For each





bivariate log-normal distribution, where log T ∗1 and log T̃ ∗2 were distributed as bivariate
normal with mean vector (µ1, µ2) = (2.5, 1.5), standard deviations (σ1, σ2) = (0.6, 0.2),
and correlation ρ = 0.4. Censoring times were generated using exponential distribution
with parameters to match the desired censoring rates. The mean, variance, and
correlation parameters were estimated from each sample and the averages were taken
while estimating the marginal survival curves on total time scale. Estimated and true
marginal survival curves were plotted for comparisons.
Figures 3.2 and 3.3 present the true and estimated marginal survival curves.
The overall performance of both the non-parametric and parametric methods were
satisfactory to estimate the true survival curves using the simulated data. The
estimates for the first event in the sequence were relatively more close to the truth
when compared to the second event for both approaches irrespective of sample size
and censoring rate. However, the bias in the estimates of marginal survival for the
second event diminished for both approaches with higher sample sizes. The estimates
remained robust to increase in censoring rate from 10% to 30% in all cases.
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Figure 3.2: Comparison of true and NPMLE estimates of marginal survival curves for
two sequential time-to-event. Different sample sizes and censoring rates were used,
and 1,000 samples were generated in each simulation setup.
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Figure 3.3: Comparison of true and log-normal model estimates of marginal survival
curves for two sequential time-to-event. Different sample sizes and censoring rates
were used, and 1,000 samples were generated in each simulation setup.
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3.4 Applications
As the infection HIV has no known cure, for patients living with HIV infection, the
primary goal of treatment is to keep the level of viral load (VL) at a suppressed
(undetectable) level (Lima et al. 2008; Cohen et al. 2011). Studies have reported
that sustained viral suppression significantly decreases the rate of HIV transmission
(Montaner 2011). And also plays a crucial role to improve human body’s immune
system and thereby reduces the risks of other morbidity and mortality (Hogg et al.
1998; Sighem et al. 2003; Lima et al. 2007). If able to maintain a suppressed VL,
patients with HIV/AIDS now may expect a life like non-infected people (Hogg et al.
1998; Sighem et al. 2003).
Given the advancement of antiretroviral therapy (ART), HIV patients now can
quickly reach a state of suppressed VL. However, it is important to maintain the
suppressed VL to utilize the full advantages of ART treatment. Recent studies, in the
United States and Canada, have reported that the viral suppression following ART
initiation did not sustain for a considerable proportion of HIV patients (Yehia et al.
2012; Palmer et al. 2018; Crepaz et al. 2018). Following the viral suppression, certain
groups of patients fail to maintain it and, unfortunately, rebound to the detectable
viral load and thus be at higher risk opportunistic comorbidity and mortality.
We have used the non-parametric and parametric methods presented in this study
to analyze the VL rebound behavior among South Carolina (SC) HIV/AIDS patients
diagnosed between 2004-2013. We considered the patients diagnosed with detectable
VL and analyzed their 24 months post-diagnosis VL rebound behavior. We defined
the detectable and undetectable (suppressed) VL states as VL ≥ 200 and VL <
200 copies/mL, respectively. We estimated the marginal survival functions for both
the VL suppression (detectable to undetectable VL) and rebound (undetectable to
detectable VL following the VL suppression). We employed both the non-parametric
and parametric approaches to estimate the VL suppression and rebound survival.
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A total of 5,202 patients in SC were diagnosed with HIV/AIDS in the time between
January 1, 2004, to December 31, 2013. 5,169 of whom were adults (aged ≥ 13). 3,238
of the adult patients had at least two non-missing viral loads (VL) measurements in
the first 24 months of diagnosis. 2,578 of these 3,238 patients were diagnosed with
detectable VL and thus were retained in the analysis sample. 75.18% (n = 1945) of
the patients in the sample attained suppressed (undetectable) VL within the follow-
up period of 24 months. 21.95% (n = 427) patients with suppressed VL further
rebounded back to the detectable VL within the 24 months post-diagnosis period.
While combining the entire VL rebound process, one-in-every six (16.50 %) patients
diagnosed with detectable VL experienced VL rebound following a suppression within
the 24 months of HIV diagnosis.
Figure 3.4: The distributions of observed event times and log-transformed event times
for the sequential time-to-events in the process of VL rebound.
A preliminary examination of the observed event gap times for the two sequential
events showed a negative product-moment correlation (-0.31), which was expected
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as the two sequential events under investigation (VL suppression and rebound) are
opposite in nature. We plotted the densities of the observed event times in Figure
3.5 in both the original and log scales. The log-transformed event times did not
appear to follow a normal distribution. Despite the correlated nature of the events
and deviation from normal in event times distributions, we decided to apply both
methods to estimate the marginal survival curves of the events of VL suppression and
VL rebound. The estimated survival curves are presented in Figure 3.5. As the first
event (VL suppression) was truly independent of censoring times, we observed both
the non-parametric and parametric methods provided almost identical estimates of
the survival function for this event.
Figure 3.5: Estimated marginal survival probabilities for the two sequential time-to-
event involved in the process of VL rebound among HIV/AIDS patients. The NPMLE
estimates are in the left panel, and log-normal estimates are in the right panel.
The survival probabilities for VL suppression at 3 months, 6 months, 9 months,
and 12 months were estimated to be 0.90, 0.72, 0.58, and 0.46. The high negative
slope of the VL suppression marginal survival curve indicated that treatment initiation
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and changes in life-style following diagnosis helped the patients very well to attain a
quick VL suppression. While looking at the estimated marginal survival curves for
the second event in our VL rebound sequence, the estimates from non-parametric
and parametric approaches differed. Both methods captured the negative association
between the two events in general, however, the non-parametrically estimated survival
probabilities were slightly lower compared to those from the parametric approach,
probably due to the assumption of independence in estimation.
Figure 3.6: Estimated parametric conditional survival probability curves of detectable
VL rebound given the time of VL suppression. Each conditional curve starts from the
time of observing the VL suppression event and continues to the end of considered
follow-up period (24 months post-diagnosis).
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As presented in Figure 3.6, we further have explored the condition survival proba-
bilities of VL rebound in the follow-up window given the VL suppression observation
times ranging from 0 to 24 months. The increasing negative slopes of the parametric
conditional curves of VL rebound at increasing VL suppression time on which they are
conditioned, further revealed more information on the negative association between the
two sequential event times. Patients who attained an early VL suppression managed
to sustain that for long. In contrast, the patients who needed a longer time to reach
the suppressed VL state did not maintain the suppressed VL for long before they
experience a VL rebound.
3.5 Discussion
Data on multiple sequential time-to-events are persistent in follow-up clinical studies,
and thus the estimation of survival functions of such event process gained the attention
of many researchers. Because of the complex nature of the data and violation of the
independent censoring assumption due to the correlated nature of successive event
times make the problem of survival curve estimation difficult. Several estimators
for the conditional survival functions of the gap times between consecutive events
have been discussed previously by different authors. Practical usage of most of these
estimators in literature are limited by their complexity and assumptions made during
the derivations apart from the fact that many of them are applicable to data on only
two sequential time-to-events.
In this study, we have revisited the problem and discussed two straightforward
methods of estimating the marginal survival functions of the total event times and
conditional survival functions of the successive event gap times. We have discussed a
non-parametric approach of estimating the marginal survival functions of multiple
sequential time-to-events under an assumption of independence between the consecu-
tive event times. The non-parametric estimator is very simple and can be estimated
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using the Kaplan-Meier survival estimates at the time-to-event gap times. The second
method that we have discussed is fully parametric and utilized the excellent properties
of multivariate log-normal distribution for easy computations of both marginal and
conditional survival functions for sequentially observed time-to-events.
Despite being easy to understand and to implement, the discussed methods are
not free of limitation while considering their applications to practical data analyses.
Relaxing the dependence nature of the event times made it possible to have a very
simple estimator for the marginal survival functions of successive events; however, one
is expected to be cautious while employing this method in practice. The ignorance of
dependence between event times, while evident, may cause to have biased estimates
of the survival functions. While the fully parametric approach offers an easy solution
to account for the event time dependence, it imposes assumption on the event time
distribution at the same time. This may restrict the application of this approach in
situations where the event times are not log-normally distributed.
We have studied the finite sample properties of both of our non-parametric and
parametric approaches at different sample sizes and censoring rates through statistical
simulations and found satisfactory performances. Demonstrations of analyzing viral
load rebound behavior among HIV/AIDS patients, a problem involving two sequential
time-to-events defined by viral suppression and viral rebound, has been presented. If
the assumptions can be met, the discussed approaches provide by far straightforward
means of estimating the sequential event time survival functions compared to the
other approaches in the literature.
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Chapter 4
Joint Modeling of Multivariate Longitudinal
Outcomes and Multiple Sequential
Time-to-Event Data
4.1 Introduction
Chapter 2 of this dissertation introduced a semiparametric latent trait joint frailty
model for analyzing multivariate longitudinal outcomes and multiple time-to-event
data while presence of a terminal event was considered. The proposed joint model in
Chapter 2 assumed the non-terminal event times to be unordered. That is, different
individuals in a study may experience the time-to-events in different orders. However,
in many clinical studies, subjects may experience multiple time-to-event that follows
a natural sequence, and a following event can not be observed without observing the
previous events. In some cases, the events may be of the same nature (e.g., recurrent
disease episodes) or of different natures in other cases (e.g., stages of HIV infection). If
the time-to-events are of the same nature they are referred to as recurrent events (Cook
and Lawless 2007). The current chapter discusses an extension of the model presented
in Chapter 2 for jointly analyzing multiple sequentially observed time-to-events and
multivariate longitudinal outcomes.
Analysis of sequential time-to-events can be very beneficial to predicting complex
disease processes as well as understanding the within and between association among
event times and disease biomarkers. Given the practical needs, the problem of a
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joint analysis of sequential time-to-event and longitudinal outcomes has received
much attention in recent years. However, the relevant joint modeling literature is
limited to methodologies for analyzing sequential time-to-events of the same type
i.e., the recurrent events. Henderson, Diggle, and Dobson (2000) first considered
analysis of the recurrent event in joint modeling framework. Henderson, Diggle,
and Dobson (2000) adopted the general recurrent event time model of Peña and
Hollander (2004) within the latent class approach of Lin et al. (2002) and presented a
parametric joint model of recurrent events and a single longitudinal outcome. This
early work of Henderson, Diggle, and Dobson (2000) was followed by many other
recurrent event joint model extensions to date. These later developments included
joint models for a single longitudinal outcome and a single recurrent event with or
without presence of a terminal event (e.g., Liu, Huang, and O’Quigley 2008; Liu
and Huang 2009; Kim et al. 2012; Mazroui et al. 2012; Efendi et al. 2013; Król
et al. 2016; Njagi et al. 2016; Shen, Huang, and Guan 2016); a single recurrent event
and multivariate longitudinal outcomes (Musoro, Geskus, and Zwinderman 2015);
multivariate longitudinal outcomes and two recurrent events (Mazroui et al. 2013);
multi-type recurrent events and a terminal event (Lin et al. 2017); and more recently,
for multivariate outcomes and multi-type recurrent events in presence of a terminal
event Hof et al. (2017). More details on these recurrent event joint models have been
discussed in the Section 1.2.2 of Chapter 1.
The vast studies for recurrent events in the joint modeling literature addresses the
problem of analyzing sequential time-to-events only partially and especially cover the
problems of sequential events of the same nature. However, in the cases where the
sequential time-to-events are of different nature, these models may not apply. The
uniqueness of the problem with sequential time-to-events of different types lies in the
fact that if the events are of different types, the risk profile of them with respect to
the covariates may vary and need to be estimated using different sets of regression
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parameters. The analyses of recurrent event data may not have such concern as the
events are of the same type, and a common covariate effect size may be assumed.
In this chapter we extend our proposed joint modeling approach in Chapter 2 for
analyzing data involving multivariate longitudinal outcomes and multiple sequential
time-to-event. Following the similar approach, we present a Bayesian joint frailty
model that accounts for all the possible sources of correlations including the within
and between the longitudinal and time-to-events using the respective submodels and
connects the submodels through shared parameters. We discuss a Bayesian method of
estimating the model parameters and a Markov chain Monte Carlo (MCMC) approach
of obtaining dynamic predictions on the longitudinal outcome trajectories and time-
to-event risks. Along with the statistical simulation studies evaluating performances
of the model estimation and prediction algorithms, we present a demonstration of
applying the proposed model to analyze the viral load (VL) rebound differentials
among the HIV/AIDS patients in South Carolina (SC).
The rest of the chapter is organized as follows. Sections 4.2 and 4.3, respectively
present the proposed model and the parameter estimation algorithm. Section 4.4
outlines the dynamic prediction methods. Section 2.6 presents the simulation study
setup and results; Section 2.7 demonstrate an application of the proposed model.
Section 2.8, as the final section of this chapter, discusses the contributions made in
this chapter.
4.2 Methods
Let us consider a study where a set of n individuals being followed for a preset time
length and data are being recorded on M longitudinally measured outcomes and K
sequential time-to-event outcomes. Let yijm(t) = yim(tij) denotes the observed value
of mth (m = 1, 2, . . . ,M) longitudinal outcome at time tij (j = 1, 2, . . . , ni) for the
ith individual where i = 1, 2, . . . , n. We use the vector yim = {yim(tij); 0 ≤ tij ≤
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Ti; i = 1, 2, . . . , n; j = 1, 2, . . . ni} to denote the values of mth longitudinal outcome
observed ni times in the time interval [0, Ti).
Let us further consider that the ith individual experience the K sequential time-to-
events at the true event times T ∗i1 < T ∗i2 < . . . < T ∗i(K−1) < T ∗iK = T ∗i , where T ∗i = T ∗iK
is the total time ith individual needs to experience all the K events. Note that the
event times T ∗ik (k = 1, 2, . . . , K) denote the event times measured from the start of
follow-up to event. For k > 1, let T̃ ∗ik = T ∗ik−T ∗i(k−1) denote the true gap time between
the (k − 1)th and kth sequential time-to-events. For k = 1 (first event in sequence)
the gap time equals the event time i.e., T̃ ∗i1 = T ∗i1. The event times are subject to
univariate right censoring by Ci, which we assume to be independent of event times.































Figure 4.1: A demonstration of the data collection process on multivariate longitudinal
outcomes, and multiple sequential time-to-events.
Due to the right censoring, we do not observe the true event times. Thus for
an individual ith, rather than observing (T ∗i1, T ∗i2, . . . , T ∗i(K−1), T ∗iK = T ∗i ), we observe
(Ti1, Ti2, . . . , Ti(K−1), TiK = Ti, δi1, δi2, . . . , δi(K−1), δiK), where Tik = min(T ∗ik, Ci) and
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the event indicator to be δik = I(T ∗ik ≤ Ci); k = 1, 2, . . . , K. T ∗ik and Ci are the true
event time and censoring time, respectively as denoted above. Given the (k− 1)th and
kth events are observed in the follow-up period, T̃ik = Tik−Ti(k−1) denote the observed
gap times between the consecutive events. It is to be noted that, an individual i can
be at risk of an event k > 1 if and only if the individual has already observed the
previous events 1, 2, . . . , (k − 1). Let us denote the number of individuals at risk of
kth event in sequence by nk where, k = 1, 2, . . . , K, n1 = n as the entire sample is at
risk of experiencing the first event, and n = n1 ≤ n2 ≤ . . . ≤ nK . Say, the notation
Rk denotes the set of individuals at risk for kth time-to-event.
To derive a joint statistical model for the above presented longitudinal and time-
to-event data, we define separate submodels for the longitudinally observed outcomes
and the time-to-events. The longitudinal and time-to-event submodels are then linked
using shared parameters. Using the similar approach presented in Chapter 2, we use a
multivariate semiparametric multivariate latent trait generalized linear mixed model
(LTGLMM) (Wang, Luo, and Li 2017) to model the dependencies and developments
of the longitudinal outcomes over time. Semiparametric hazard regression approach is
used to model the risks of sequential time-to-events. The time-to-event submodels
share the longitudinal outcomes through the latent trait.
4.2.1 Submodel Definitions
Let us assume that Γi(t) denotes value of a latent trait for ith (i = 1, 2, . . . , n)
individual at any observation time t. In the first step of defining the semiparametric
multivariate LTGLMM, we express the mth (m = 1, 2, . . . ,M) longitudinally observed
outcome yim(t) for ith individual at time t as a function of the latent trait
ηijm(t) = fm [µijm(t)] = ϕm + Γi(t)ψm + εijm(t), (4.1)
where, yijm(t) follows a distribution in the exponential family with mean µijm(t). The
term εijm(t) denotes the measurement errors associated with the mth longitudinal
78
outcome. We assume the measurement errors for the M longitudinal outcomes
εij(t) = (εij1(t), εij2(t), . . . , εijM(t)) to follow a multivariate normal distribution as,
εij(t) iid∼ N(0,Σε). As we discussed in Chapter 2, the semiparametric multivariate
LTGLMM for the longitudinal outcomes offers parsimony and computational efficiency
by using a univariate latent trait to represent the M longitudinal outcomes.
The regression parameters ψm in Equation (4.1) measure the expected change
in yijm for an unit increase in the latent trait Γi(t) and ϕm = E [yijm(t)|Γi(t) = 0].
For a numeric continuous mth longitudinal outcome the model in Equation (4.1) can
be written as in Equation (4.2) while the Equation (4.3) presents the model for a
dichotomous longitudinally observed outcome.
yijm(t) = ϕm + Γi(t)ψm + εijm(t) (4.2)
logit [Pr (yijm(t) = 1)] = ϕm + Γi(t)ψm (4.3)
To complete the LTGLMM, a second level semiparametric linear mixed model for the
dependence of latent trait variable Γi(t) on the observed individuals’ characteristics
Γi(t) = Xi(t)β +Zi(t)αi + Gi(t), (4.4)
where, Xi is the vector of observed fixed effects covariates for ith individual and
β is the corresponding column vector of fixed effects; αi is the column vector of
random effects and Zi is corresponding covariate vector for the random effects for ith
individual which are assumed to be normally distributed as N (0,Σα). The term Gi(t)
is an unknown twice continuously differentiable smoothing function of time (t) to
allow additional flexibility and smoothing in modeling the effects of the covariates on
the latent trait. We approximate Gi(t) using a truncated power series spline (Ruppert,







where, κ = (κ1, κ2, . . . , κR) are the knots, and (t − κr)+ = t − κr if t > κr, and
0 otherwise. φ = (φ1, φ2, . . . , φR)
′ is the vector of spline coefficients assumed to
be distributed as N(0, σ2φI). To ensure the sufficient number of subjects between
the adjacent knots, we choose the location of the rth (r = 1, 2, . . . , R) knot to be
[(r + 1)/(R + 2)]th quartile of the unique observation times for the longitudinal
outcomes. We use a moderately large number of knots (usually between 5 and 20) to
ensure enough flexibility and sufficient smoothness in approximations with penalized
splines (Ruppert 2002; Eilers and Marx 1996). The Equations (4.1) and (4.4) together
present the semiparametric multivariate LTGLMM as the submodel for longitudinal
outcomes in the proposed model.
For the time-to-event submodels, we assume that the longitudinal outcomes
influence the risk of the sequential time-to-events through the latent trait. In a real
application, it may be of more interest to assess the risk of events from the time point
of experiencing the previous event. We thus model the hazard functions for the events
in the gap time scale rather than the total time since the follow-up start. If λ̃ik(t)
denotes the hazard of the kth (k = 1, 2, . . . , K) sequential time-to-event at time t
(measured from baseline) for ith (i = 1, 2, . . . , n) individual, we define proportional
hazard model as














, i ∈ Rk
(4.6)
where, t̃ = t− Ti(k−1) for k > 1 denotes the gap time between the kth, and (k − 1)th
time-to-event in the sequence. Rk represents the set of individuals at risk for the
kth sequential time-to-event, λ̃0k(.) is the baseline hazard function for kth sequential
time-to-event, Wik(t) is a vector of observed covariates for ith individual at time t,
and γk is the column vector of effect coefficients for covariates Wik(t). The fixed
effects covariate sets Xi(t) in the model Equation (4.4) for Γi(t), and Wi(t) in the
model Equation (4.6) for λ̃ik (t) may have some common covariates. For instance,
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consider that βc, and γck respectively are the effect coefficients for a covariate common
in Xi(t), andWik(t). According to an explanation by Ibrahim, Chu, and Chen (2010),
γck and (γck + ϑkβc) respectively measure the direct, and total covariate effects on
the kth time-to-event risk. The association parameter ϑk measures the effect of the
latent trait Γ(t) on the risk of kth (k = 1, 2, . . . , K) sequential time-to-event event
at time t. For instance, ϑk = 0 implies that there is no effect of the latent trait on
the risk of kth time-to-event. The parameters υk′ (k′ = 1, 2, . . . , k − 1) measures
direct effect, on the kth event, of the gap time spent before experiencing the (k− 1)th
event where, k = 2, 1, . . . , K. The term ωik denotes the kth time-to-event frailty, and
we assume them to be independent of covariates in the model. The frailty vector
ωi = (ωi1, ωi1, . . . , ωiK) is assumed to have a multivariate normal distribution with
mean 0, and covariance matrix Σω, whose off-diagonal elements govern the correlation
among risks of different time-to-events. For example, a positive off-diagonal element
σω,kk′ of the matrix Σω indicates a positive correlation between the risks of events k,
and k′, where k, k′ = 1, 2, . . . , K, and k 6= k′.
As a specified and smoothed baseline hazard function is required for predicting
individual-specific survival probabilities, we adopt a truncated power series spline
(Ruppert, Wand, and Carroll 2003) approximation for the baseline hazard functions










= VkR(t̃) ζk, (4.7)
where, χk = (χk1, χk2, . . . , χkR) are the knots, and (t̃−χkr)+ = t̃−χkr if t̃ > χkr, and
0 otherwise. ζk = (ζk1, ζk2, . . . , ζkR)
′ is the vector of spline coefficients, and assumed to
be distributed as N(0, σ2ζkI) to avoid overfitting (Crainiceanu, Ruppert, Wand, et al.
2005; Ruppert, Wand, and Carroll 2003). Location of the rth (r = 1, 2, . . . , R) knot
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for the kth time-to-event is chosen to be [(r + 1)/(R + 2)]th quartile of the unique
kth event gap times.
4.3 Bayesian Estimation
Under the assumptions of conditional independence of the longitudinal outcomes




, given the random effects
and the frailties respectively, we can write the log-posterior for the ith individual as
following

















where, yi = {yijm; j = 1, 2, . . . , ni,m = 1, 2, . . . ,M} is the set of longitudinal outcomes
observations collected from ith individual and θ is the vector of all population level
model parameters in Equations (4.1), (4.4), and (4.6). The function ∆i(k) takes value
1 if k = 1 or δi(k−1) for k > 1. The corresponding log-posterior can be re-written as














logPr(αi|θ) + logPr(ωi|θ) + logPr(θ)
]
, (4.9)
where, ∑nij=1 logPr (yijm(t)|αi,θ) is the log-posterior contribution of ith individual for





ith individual’s log-posterior for the kth time-to-event in the sequence. logPr(αi|θ)
is the ith log-posterior for the distribution of random effects in the longitudinal
submodels, logPr(ωi|θ) is the ith individual’s log-posterior for the distribution of
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frailty terms, and the term logPr(θ) represents the joint prior distribution across
all the remaining population-level parameters. The log-posterior contribution of an
individual i for the kth (k = 1, 2, . . . , K) event in the sequence in the Equation (4.9)




































is given by Equation (4.6). As the
integral in the definition of survival function in Equation (4.10) does not have an
analytical solution, we use Gauss-Kronord quadrature technique to approximate
it. Usage of standard numerical integration techniques such as Monte Carlo and
Gaussian quadrature can be found in joint modeling literature (Rizopoulos 2011;
















where, wq and sq, respectively are the standardized weights and locations (abscissa)
for qudrature node q (q = 1, 2, . . . , Q) (Laurie 1997). We chose Q = 15 nodes for the
approximations.
In our Bayesian estimation algorithm, we assume vague priors for all the model
parameters. We assume the prior distribution N(0, 100) for all population-level
parameters; Uniform[0, 1] for all correlation parameters in covariance matrices; and
Inverse-Gamma(0.01, 0.01) for all variance parameters. To obtain the samples from
full conditional posteriors of the parameters, we use Hamiltonian Monte Carlo (Duane
et al. 1987) and No-U-Turn sampler (Hoffman and Gelman 2014) implemented in a
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probabilistic programming language, Stan (Carpenter et al. 2017). Stan has been
reported to be efficient in achieving faster convergence and requiring a lower number
of samples compared to other Bayesian languages such as BUGS (Hoffman and Gelman
2014). To estimate the model parameters, we used four parallel Markov chains, each
with 2,000 iterations, where the first 1,000 iterations were discarded as burn-in. We
used the Gelman-Rubin diagnostic to ensure the convergences by observing the scale
reduction factor R̂ of all parameters to be less than 1.1 (Gelman et al. 2013).
4.4 Dynamic Prediction Algorithm
Let us consider that Dn = {yi, Tik, T̃ik, δik; i = 1, 2, . . . , n, k = 1, 2, . . . , K} denotes
the collection of longitudinal outcomes and sequential time-to-events data from the
sample used to fit (training data) the joint model. Let us consider that an individual
ι, not in the model training dataset, has been followed until time tobs since the







ιk; k = 1, 2, . . . , (k − 1)
)
denotes the follow-up history of the










T̃ oι1 = T oι1, T̃ oι2, . . . , T̃ oι(k−1)
)
denotes the observed event times in total and gap time scales, respectively for the
(k − 1) sequential time-to-events (prior to the kth event in interest) for individual ι.
Given the follow-up history of subject ι until the calendar (since start) time tobs, we
can calculate the predicted longitudinal outcomes trajectories as well as the conditional
survival/failure probabilities for the kth sequential event until some future time point
t′ > tobs.
To obtain the dynamic predictions on the longitudinal outcomes trajectories and
the time-to-event risks, we first draw samples of the individual ι’s random effects from
the posterior distribution Pr
[
αι,ωι
∣∣∣ T̃ ∗ιk > tobs − Tι(k−1),Dι(tobs),θ]. We consider that
θ(`) (` = 1, 2, . . . ,L) denotes a vector of the samples from the posterior distributions
of the population-level parameter vector θ. Then, assuming that the random effects
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and the frailties are independent of covariates and conditioning on the `th posterior
sample θ(`), we can draw the `th sample of the random-effects from the posterior





































∣∣∣αι,ωι,θ(`)) × Pr [αι,ωι ∣∣∣θ(`)] , (4.12)
where, the survival functions for kth sequential time-to-event can be written in terms













and the cumulative hazard functions can be computed using the Gauss-Kronord
quadrature outlined in the Equation (4.11). For each sample θ(`) (` = 1, 2, . . . ,L) of






using an adaptive rejection Metropolis algorithm (Gilks, Best, and Tan 1995) and retain
the final sample. Given that the individual ι doesn’t experience the kth time-to-event
by time t′, the observation history then gets updated to Dι(t′). The joint posterior
distribution of random effects is updated to Pr
[
αι,ωι
∣∣∣ T̃ ∗ιk > t′ − Tι(k−1),Dι(t′),θ],
and we can draw new samples to dynamically update the predictions.





ι , ` = 1, 2, . . . ,L
)
drawn for the individual ι, the predictions
can be obtained by plugging in the parameter values in respective model equations. For
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instance, the `th predicted value for a numerical continuous and a binary longitudinal
outcomes are computed using the Equations (4.13) and (4.14), respectively in following
y
(`)











= ϕ(`)m + Γ(`)ι (t′)ψ(`)m , (4.14)




. Each parameter is replaced using the corresponding
element in (θ(`),α(`)ι ,ω(`)ι , ` = 1, 2, . . . ,L). The `th value of the latent trait and the
`th value of ιth individual’s hazards at time t′ for kth event can obtained as






∣∣∣α(`)ι ,ω(`)ι , ] = λ̃0k (t′ − Tι(k−1)) exp











Given the follow-up history Dι(tobs), we can compute the conditional gap time
failure probability for the kth sequential event by time t′ as
ˆ̃πιk(t′|tobs) = Pr
[
T̃ ∗ιk ≤ t′ − Tι(k−1)






T ∗ιk ≤ t′ − Tι(k−1)










T ∗ιk ≤ t′ − Tι(k−1)
∣∣∣T ∗ιk > tobs − Tι(k−1),αι,ωι,θ]×
Pr
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1− S̃ιk′(t′ − Tι(k−1) |T ∗ιk > tobs − Tι(k−1),αι,ωι,θ)
]
×













′(t′ − Tι(k−1) |αι,ωι,θ)
S̃ιk′(tobs − Tι(k−1) |αι,ωι,θ)
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Pr [αι,ωι | Dι(tobs),θ] d (αι,ωι) (4.17)
Due to the multidimensional integral with respect to (αι, ωι) involved in Equations
(4.17), we approximate ˆ̃πιk(t′|tobs) using the Monte Carlo method by plugging in the
already drawn L posterior samples of population and individual level parameters
(Rizopoulos 2011). The `th (` = 1, 2, . . . ,L) approximation for the event probabilities


































Once the L posterior values are obtained for the longitudinal outcomes and the
event probabilities, the predictions can be obtained by computing the summaries (e.g.,
mean, median, quantiles) of the posterior value distributions.
4.5 Assessing Model Predictive Performance
As discussed in detail in the Section 2.5 of Chapter 2, we use the areas under curve
(AUC) for the time-dependent receiver operating characteristics (ROC) curves as a
measure of discrimination (Li, Greene, and Hu 2018), and expected dynamic Brier
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score (DBS) as a measure of calibration (Sène et al. 2016; Proust-Lima et al. 2014)
to assess the predictive performance of our proposed joint model for multivariate
longitudinal outcomes and multiple sequential time-to-events.
4.5.1 Area Under ROC Curve
For any given cut-point c ∈ (0, 1), we can define time-dependent sensitivity and
specificity based on the predictive distribution of the censored event times as (Li,
Greene, and Hu 2018)
Sensitivity : P̂r
[
π̃ik(t′|tobs) > c | T̃ ∗ik > tobs − Ti(k−1),
I
(











π̃ik(t′|tobs) > c | T̃ ∗ik > tobs − Ti(k−1),
I
(















where, the gap time indicator function I
(
tobs − Ti(k−1) < T̃ ∗ik ≤ t′ − Ti(k−1)
)
indicates
if the ith individual experienced the kth event, in the total time interval (t, t′].
We label the individuals with I
(
tobs − Ti(k−1) < T̃ ∗ik ≤ t′ − Ti(k−1)
)
= 1 as cases and
individuals with I
(
tobs − Ti(k−1) < T̃ ∗ik ≤ t′ − Ti(k−1)
)
= 0 as controls. The weights
Φ̂i(t, t′) account for the censored event times, and is defined as in the following. It is
important to note that the individuals that experienced the event before time tobs,
i.e., T̃ik < tobs − Ti(k−1) do not have any contribution while computing the individual
weights.
Φ̂i(t, t′) = I
(











T̃ ∗ik < t
′ − Ti(k−1)
∣∣∣ T̃ ∗ik > tobs − Ti(k−1), ˆ̃πik(t′|tobs)]
= I
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T̃ ∗ik ≥ T̃ik
∣∣∣ ˆ̃πik(t′|tobs)]
 , (4.21)
where, the conditional survival distributions, Pr
[
T̃ ∗ik ≥ τ
∣∣∣ ˆ̃πik(t′|tobs)] (τ can be either
t′ − Ti(k−1) or T̃ik) in Equation (4.21) can be estimated using a kernel-weighted
Kaplan-Meier method with a specified bandwidth b (Li, Greene, and Hu 2018) as
P̂r
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where, Ωk (k = 1, 2, . . . , K) denotes the set of distinct event times (i.e., T̃ik’s with
δik = 1), and Kb is the kernel function with bandwidth b. We use a uniform kernel in
this study. Li, Greene, and Hu (2018) demonstrated through numerical study and
theoretical arguments that the estimates are insensitive to misspecification of kernel
bandwidth.
Using the estimated sensitivity and specificity values for all possible cut points
c ∈ (0, 1), we can construct the time-dependent ROC curve by plotting the sensitivity
against 1 - specificity and can obtain the corresponding AUC for the time horizon (t, t′]
using any standard method of numerical integration (e.g., Simpson’s rule, Trapezoidal
rule, etc.). The value of AUC can range from 0 to 1 with AUC = 0 meaning no
discriminatory power from model predictions, AUC = 0.5 implies nothing better than
a random guess, and AUC = 1 indicates perfect discrimination.
4.5.2 Dynamic Brier Score
For kth (k = 1, 2, . . . , K) time-to-event, the expected DBS is defined as
E
[




where, ∆i(t′ | tobs) denotes the observed status of the event in interest for the time
horizon (t, t′] and takes value 1 if the individual i experience the kth sequential event










∣∣∣ tobs)− ˆ̃πik(t′ ∣∣∣ tobs)}2] , (4.24)
where, nktobs is the number of individuals at risk at time tobs for the kth event. The




























where, the notation ˆ̃S0k(.) denotes the Kaplan-Meier estimates of survival probabilities
(Sène et al. 2016). The value of DBS presents an account of bias in the predicted
outcomes, and a lower BS value implies higher predictive accuracy. While a BS = 0
indicates perfect prediction, BS = 0.25 implies nothing better than random guess.
4.6 Simulation Studies
To investigate the performances of the proposed model, parameter estimation, and
dynamic prediction algorithm, we performed statistical simulation studies. We gener-
ated 250 datasets with n = 400 individuals in each. For each simulated dataset, we
generated data on M = 2 continuous longitudinally observed outcomes (Yi1 and Yi2),
event times for K = 2 sequential time-to-events. For all individuals, we considered
the maximum follow-up time Ci = 24, after which the individuals were subject to be
non-informatively right-censored.
For each individual i in a simulated sample, the longitudinal outcomes observations
are generated at time points t = tij = (0, 3, 6, 9, 12, 15, 18, 21, 24). The observations
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on latent trait Γi(t), the two continuous longitudinal outcomes (Yi1, Yi2), the two
sequential event gap times (T̃i1 and T̃i2) were generated using
Γi(t) = β0 + β1Xi1 + β2t+ αi0 + αi1t, (4.26)
Yi1(t) = ϕ1 + Γi(t)ψ1 + ε1(t), (4.27)
Yi2(t) = ϕ2 + Γi(t)ψ2 + ε2(t), (4.28)







γ21Xi1 + ϑ2Γi(t) + υ1T̃i1 + ωi2
]
, (4.30)
where, T̃i1 = Ti1 denotes the time to observe the first event in sequence. X1 is consid-
ered to be a dichotomous baseline covariate and generated from a Binomial distribution
with success probability 0.50. The regression parameters in latent trait model in the
Equation (4.26) was set as (β0, β1, β2) = (1.20, 0.80, 0.90) and the two random effects
were generated from a bivariate normal distribution with standard deviations and
correlation parameters set to (σα0 , σα1 , ρα) = (0.75, 0.55, 0.25). The regression parame-
ters to generate the two continuous longitudinal outcomes, in the Equations (4.27) and
(4.28), were set as (ϕ1, ϕ2) = (2.00, 3.00) and (ψ1, ψ2) = (1.10, 0.75). We generated
the longitudinal outcomes measurement errors from a bivariate normal distribution
with the standard deviations and correlation, (σε1 , σε2 , ρε) = (0.90, 0.65, 0.30). The
baseline covariate (X1) effects and the latent trait effects on the first and second
events, in Equations (4.29), and (4.30), were set as (γ11, γ21) = (0.50,−0.30) and
(ϑ1, ϑ2) = (0.40,−0.20) respectively. The effect of first event time on the risk of
observing the second event was set as υ1 = −0.10. We generated the time-to-event
frailties from bivariate normal distribution with standard deviations and correlation
parameters as (σω1 , σω2 , ρω) = (0.20, 0.15,−0.25). For simplicity, we assumed the
baseline hazards for both the sequential events to be constant in this simulation
study and were set as (λ01, λ02) = (0.65, 0.25). For each simulated data set, we first










if the first event was not censored.





with the censoring time (Ci). 75% (n = 300) individuals
of each generated dataset were used as training data to estimate the parameters, and
we used the remaining 25% (n = 100) as the test data for validation purposes.
Table 4.1: Parameter estimation performance of the proposed model
using simulated training data.
Parameter True Value Estimate Bias SE CP RMSE
Latent Trait (Γ)
β0 1.20 1.202 0.002 0.103 0.948 0.103
β1 0.80 0.797 -0.003 0.150 0.948 0.150
β2 0.90 0.899 -0.001 0.056 0.960 0.056
σα0 0.75 0.741 -0.009 0.053 0.941 0.053
σα1 0.55 0.545 -0.005 0.038 0.936 0.038
ρα 0.25 0.250 0.000 0.098 0.960 0.098
First Longitudinal Outcome (Y1)
ϕ1 2.00 1.998 -0.002 0.039 0.958 0.039
ψ1 1.10 1.101 0.001 0.014 0.956 0.014
σε1 0.90 0.899 -0.001 0.012 0.958 0.012
ρε 0.30 0.302 0.002 0.087 0.920 0.087
Second Longitudinal Outcome (Y2)
ϕ2 3.00 3.001 0.001 0.028 0.941 0.028
ψ2 0.75 0.750 0.000 0.010 0.956 0.010
σε2 0.65 0.649 -0.001 0.009 0.941 0.009
ρε 0.30 0.302 0.002 0.087 0.920 0.087
First Event (T1)
γ11 0.50 0.499 -0.001 0.162 0.960 0.162
ϑ1 0.40 0.410 0.010 0.082 0.944 0.082
σω1 0.20 0.181 -0.019 0.200 0.976 0.201
ρω -0.25 -0.265 -0.015 0.210 0.960 0.210
Second Event (T̃2)
γ21 -0.30 -0.298 0.002 0.238 0.942 0.238
ϑ2 -0.20 -0.208 -0.008 0.127 0.956 0.127
υ1 -0.10 -0.104 -0.004 0.125 0.948 0.124
σω2 0.15 0.187 0.037 0.211 0.956 0.214
ρω -0.25 -0.265 -0.015 0.210 0.960 0.210
SE = Standard Error; CP = Coverage Probability; RMSE = Root
Mean Square Error.
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Table 4.1 presents the estimated bias, standard error (SE), coverage probability
(CP), and root mean square error (RMSE) of the estimates of individual model
parameters using the simulated datasets. The bias was computed as the difference
average of posterior means and the true parameter values, SE was obtained as the
standard deviation of posterior means, and CP represents the true parameter coverage
probability of the 95% equal tail credible intervals (CrI). The results presented in Table
4.1 show that the estimates from the proposed model based on simulated training
data were obtained with small biases and RMSE. Their coverage probabilities as well
were very close to the nominal level, which is 0.95.
Table 4.2: Estimated time-dependent areas under ROC curves (AUC) and dynamic
Brier scores (DBS) for predictions of sequential time-to-events at time t′ based on
observation history at time tobs for individuals in simulated test datasets.
First Event Second Event
tobs t
′ AUC BS AUC BS
0 3 0.863 0.046 0.855 0.046
6 0.860 0.047 0.853 0.047
12 0.852 0.049 0.846 0.050
18 0.848 0.050 0.840 0.052
24 0.842 0.053 0.837 0.054
3 6 0.874 0.047 0.871 0.046
12 0.874 0.048 0.870 0.047
18 0.869 0.049 0.866 0.048
24 0.864 0.051 0.859 0.050
6 12 0.898 0.044 0.881 0.047
18 0.895 0.045 0.880 0.047
24 0.890 0.046 0.877 0.049
12 18 0.918 0.040 0.897 0.044
24 0.915 0.041 0.896 0.045
18 24 0.927 0.038 0.914 0.041
We further have used the estimated joint model for each simulated training sample
and made predictions on the probabilities of events for the sequential events, π̂ik(t′|tobs),
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and the terminal event at time t′ for the individuals in validation dataset using their
observation histories until time tobs. We then have computed the averages of time-
dependent areas under ROC curves (AUC) and dynamic Brier scores (DBS) for each
set of t′ and tobs and presented in Table 4.2. We observed that the AUC values were
high (> 0.80), indicating good discriminatory performance, and the smaller (< 0.06)
DBS values also suggested low prediction error. In general, both the AUC and DBS
measures showed trends to improve as the amount of observed data used in prediction
increases and showed a trend of drops in performance as the prediction time point (t′)
goes further from the last observation time point (tobs).
4.7 Application
In Section 3.4 of Chapter 3, we discussed that the primary goal of HIV treatment is
to keep the level of viral load (VL) of patients at a suppressed (undetectable) level
(Lima et al. 2008; Cohen et al. 2011). A maintained viral suppression can lower the
rate of the disease transmission (Montaner 2011), can improve the patients’ body
immune system further reducing risks of other adverse health conditions (Hogg et al.
1998; Sighem et al. 2003; Lima et al. 2007), and eventually can lengthen the life
expectancy (Hogg et al. 1998; Sighem et al. 2003). We also have noted that to take
the full advantages of advancements of the antiretroviral (ART) treatment and live
a life compared to uninfected people; it is very important for the HIV patients to
maintain a suppressed VL once attained. However, studies have reported that even
though most of the HIV patients, after being diagnosed with high VL, can attain a
viral suppressed (undetectable) condition, many of these patients can not maintain it
longer and returns to a detectable VL status (Yehia et al. 2012; Palmer et al. 2018;
Crepaz et al. 2018). This behavior is termed as viral load rebound behavior, and
patients observing such rebound may be exposed to a higher risk of opportunistic
illnesses and even death.
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The VL rebound among the HIV/AIDS patients is a problem of two sequentially
observed time-to-events of opposite natures. Being diagnosed with a detectable VL,
the patients are expected to observe a VL suppressed condition as the first event, and
the patients are then be at risk of having detectable VL again (rebound). In Section
3.4 of Chapter 3, we estimated the survival functions of VL suppression and rebound
for the HIV/AIDS patients in South Carolina (SC) diagnosed with detectable VL
between 2004 and 2013. Our investigation reported the VL suppression and rebound
patterns among the patients in the first 24 months of their diagnosis irrespective of
their demographic and clinical characteristics. However, previous research studies
have reported that the VL suppression and rebound intensities may considerably vary
by certain patient characteristics (Yehia et al. 2012; Palmer et al. 2018; Crepaz et al.
2018), and it may be important to identify the subgroups of patients with higher
rebound risk to plan targeted interventions.
In this study, we have applied our proposed joint frailty model for sequential time-
to-events to analyze the 24 months post-diagnosis VL rebound differentials among
SC HIV/AIDS patients. In association with the selected patient characteristics, we
have utilized the data on longitudinally observed CD4 cell counts (cell/mm3) in our
analysis. Even though the longitudinal submodel of the proposed joint model can
handle multivariate longitudinally observed outcomes using the latent trait modeling,
we have defined our latent trait model in this application for the only available
longitudinal outcome, CD4 cell counts. We considered an unobserved health condition
of the patients, which is assumed to be positively associated with the longitudinally
observed CD4 cell counts. The assumed latent health condition is thought of as a
measure of a patient’s physical well-being, the opposite of disease severity. We write
the corresponding model equations for the latent health condition and the longitudinal
CD4 cell counts biomarker as
√
CD4 Cell Counti(t) = ϕ1 + Latent Health Conditioni(t)ψ1 + ε1i(t),
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where, the parameter ψ1 is assumed to be positive. A higher value of the underlying
health condition reflects better health condition (representing higher CD4 cell count)
of the patients.
We have used the data from same patient sample as described in Section 2.7 of
Chapter 2 except the patients diagnosed with detectable VL only have been considered
in the analysis. The analysis sample included 879 SC adult (≥ 13 years old) HIV/AIDS
patients diagnosed between January 1, 2004 and December 31, 2016; had at least
two VL measures within 24 months of diagnosis, and were on ART treatment. The
patients were selected from all 5,169 SC adults diagnosed with HIV/AIDS in the years
between 2004 and 2013. Patients with missing VL, CD4 cell count measurements,
missing treatment information were excluded from the analysis.
The characteristics of patients in the analysis sample are summarized using de-
scriptive statistical measures and are presented in Table 4.3. The analysis sample
was dominated by higher proportions of patients aged ≥ 30 years (n = 602, 68.49%),
patients with race/ethnicity other than White (n = 711, 80.89%), and patients who
were urban resident at the time of their HIV diagnosis (n = 601, 68.37%). The male
(n = 448, 50.97%) and female (n = 431, 49.03%) patients were about evenly distributed
in the analysis sample. 61.89% (n = 544) of the patients in the analysis sample were
identified to be exposed to HIV risk other than being heterosexual. The patients
with other risk exposures include the patients injecting drug users (IDU) and the
men patients had sex with men (MSM). Half of the patients in the analysis sample
(n = 445, 50.63%) was late diagnosed as they developed AIDS by the time of their
diagnosis while the rest were diagnosed with HIV infection only. 41.75% (n = 367) of
the patients in analysis sample were given starting antiretroviral therapy (ART) with
single-tablet regimen (STR). Concerning the VL rebound behavior, 83.73% (n = 736)
patients, after being diagnosed with detectable VL, attained suppressed/undetectable
VL within 24 months post-diagnosis. 215 (29.21%) of these patients who suppressed
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their VL, experienced a VL rebound within the observation period. The proportion
of patients that experienced a complete cycle of VL rebound was 24.46% among all
the patients included in the analysis sample.
Table 4.3: Characteristics of South Carolina HIV/AIDS patients, adult, diagnosed
between 2004-2013, and included in the analysis sample (n = 879).
Characteristics Frequency (%) Characteristics Frequency (%)
Age at Diagnosis Diagnosis Type
< 30 years 277 (31.51) HIV and AIDS 445 (50.63)
≥ 30 years 602 (68.49) HIV Only 434 (49.37)
Gender Starting ART
Male 448 (50.97) STR 367 (41.75)







Risk Group VL Suppression and Rebound Frequency (%)
Heterosexual 335 (38.11) VL Suppression 736 (83.73)
Others2 544 (61.89) VL Rebound 215 (24.46)
1Black and Other Races; 2Injecting Drug Users (IDU), Men having Sex with Men
(MSM); ART = Antiretroviral Treatment; STR = Single-tablet Regimen; MTR =
Multiple-tablet Regimen; CrI = Credible Interval.
Table 4.4 and Table 4.5, respectively present the estimated (posterior means)
longitudinal submodel and time-to-event submodel parameters. As shown in Table 4.4,
the latent health condition (physical well-being) was positively associated with the
longitudinal disease biomarkers, the CD4 cell counts. Among the patient demographic
and clinical characteristics, patient age, sex, and diagnosis type were found to be
statistically significantly associated with the latent health condition (well-being).
Patients at younger ages (< 30 years) were found to be at significantly better health
condition (physically well) compared to others. The health condition of the patients
of the male sex was significantly worse compared to females. And the patients who
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were diagnosed late with developed AIDS were also found to have significantly worse
health conditions than the patients diagnosed early only with the HIV infection.
Table 4.4: Estimated longitudinal submodel parameters for the joint model of CD4
cell count and VL rebound using the data on selected (n = 879) South Carolina
HIV/AIDS patients diagnosed in the period 2004-2013.
Longitudinal Outcome
Characteristics Latent Health Condition
√
CD4 Cell Count
Coefficient (95% CrI) Coefficient (95% CrI)
Fixed Effects
Intercept 20.1 (18.99, 21.2) -18.1 (-18.5, -17.8)
Years from Diagnosis 1.12 (0.97, 1.26)
Age at Diagnosis
≥ 30 years 2.07 (1.29, 2.93)
< 30 years Ref
Gender
Male -1.92 (-2.71, -1.00)
Female Ref
Race/Ethnicity
White 0.84 (-0.15, 1.85)
Others1 Ref
Residence at Diagnosis
Urban -0.65 (-1.51, 0.16)
Rural Ref
Risk Group
Heterosexual 0.07 (-0.83, 0.96)
Others2 Ref
Diagnosis Type
HIV and AIDS -5.65 (-6.46, -4.83)
HIV Only Ref
Starting ART
STR 0.53 (-0.13, 1.25)
MTR Ref
Latent Health Condition 15.1 (14.9, 15.2)
Random Effects (SD)
Intercept 5.46
Years from Diagnosis 1.76
Random Effects Correlation -0.30
Measurement Error (SD) 2.04
VL = Viral load; 1Black and other races; 2Injecting Drug Users (IDU), Men having
Sex with Men (MSM); ART = Antiretroviral Treatment; STR = Single-tablet
Regimen; MTR = Multiple-tablet Regimen; OR = Odds Ratio; CrI = Credible
Interval; SD = Standard Deviation.
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Table 4.5: Estimated time-to-events submodel parameters for the joint model of CD4
cell count and VL rebound using the data on selected (n = 879) South Carolina
HIV/AIDS patients diagnosed in the period 2004-2013.
Sequential Time-to-Events
Characteristics VL Suppression VL Rebound
HR (95% CrI) HR (95% CrI)
Age at Diagnosis
≥ 30 years 0.85 (0.71, 1.01) 1.48 (0.84, 2.60)
< 30 years Ref Ref
Gender
Male 0.86 (0.73, 1.03) 1.13 (0.65, 2.01)
Female Ref Ref
Race/Ethnicity
White 1.24 (1.02, 1.50) 0.70 (0.36, 1.30)
Others1 Ref Ref
Residence at Diagnosis
Urban 1.06 (0.91, 1.25) 0.98 (0.60, 1.65)
Rural Ref Ref
Risk Group
Heterosexual 0.96 (0.80, 1.14) 1.12 (0.66, 1.90)
Others2 Ref Ref
Diagnosis Type
HIV and AIDS 1.74 (1.48, 2.06) 0.51 (0.31, 0.84)
HIV Only Ref Ref
Starting ART
STR 1.00 (0.87, 1.05) 0.74 (0.46, 1.18)
MTR Ref Ref
Latent Health Condition 1.02 (1.01, 1.03) 0.98 (0.96, 1.00)
VL Suppression Time 1.01 (0.85, 1.19)




VL = Viral Load; 1Black and other races; 2Injecting Drug Users
(IDU), Men having Sex with Men (MSM); ART = Antiretroviral
Treatment; STR = Single-tablet Regimen; MTR = Multiple-
tablet Regimen; HR = Hazard Ratio; CrI = Credible Interval;
SD = Standard Deviation.
As shown in Table 4.5, we found that patient race, diagnosis type, and the latent
health condition statistically significantly influenced the patients’ VL suppression
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event. While the risk of VL rebound following the VL suppression among the patients
were statistically significantly influenced by HIV diagnosis type and latent health
condition. The estimated joint model revealed a weak negative correlation between
the frailties of the two sequential time-to-events: VL suppression and VL rebound.
The patients of White race/ethnicity were found to attain the suppressed VL, after
being diagnosed with detectable VL, at a significantly higher rate compared to patients
of other races. It was interesting to observe that the patients diagnosed late with
developed AIDS attained suppressed VL at a faster rate than the patients diagnosed
with HIV only. At the same time, the late-diagnosed AIDS developed patients were
at significantly lower risk of detectable VL rebound following the suppression. It may
be believed that the additional risks of comorbidity and mortality among the late
diagnosed patients might have helped the them being careful in lifestyle and more
adherent to the treatment, which resulted in faster rate of VL suppression as well as
lower risk of VL rebound. The other patient characteristics, including the time to VL
suppression, did not exhibit statistically significant influences on VL rebound risk.
4.8 Discussion
Observations on longitudinal outcomes and ordered time-to-events are frequent in
many clinical follow-up studies. In some studies, the ordered time-to-events in interest
are of the same type i.e., the recurrent events, whereas the events are of different
types in other cases. The statistical joint modeling literature for analyzing recurrent
time-to-events is very well developed and provides modeling options for data with
single or multivariate longitudinal outcomes in conjunction with single or multiple
time-to-event with or without the presence of dependent censoring from a terminal
event.
The applications of existing joint models for ordered time-to-event data are limited
to recurrent events of the same type only where it is assumed that the risk profile of
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each recurrence is uniformly influenced by the covariates and the longitudinal outcomes.
However, in problems where the ordered time-to-events are of different types, the
assumption of uniform covariate influence is not likely to be valid, and each of the
time-to-events may require separate effect-size estimates for explaining the risk profile.
This current study has presented a semiparametric latent trait joint frailty model
for analyzing multivariate longitudinal outcomes and multiple ordered time-to-events.
We termed the ordered time-to-events as sequential time-to-events as they occur
in a particular sequence. The proposed model consists of two kinds of submodels.
First, multivariate latent trait mixed-effects submodels for the longitudinally observed
outcomes. These submodels capture the simultaneous development of the longitudinal
outcomes through time and accounts for the interrelation between outcome values from
same individual, as well as the between individual dependency over time. The second
type of submodel is survival models sharing the latent terms with the longitudinal
outcomes submodels and use time-to-event specific frailties which are assumed account
for the correlation between the time-to-events. The survival submodels are defined
by the gap times between the consecutive time-to-events and use the previous events’
gap times as covariates to assess their effects on the following event. The longitudinal
outcomes are considered to influence the risk of sequential time-to-events via their
true values. We further have presented an algorithm for dynamically predicting the
multivariate longitudinal outcome trajectories as well as the risks of the sequential
time-to-events.
While developments and extensions of statistical joint models for multivariate
longitudinal outcomes and multiple time-to-event might have been limited due to
the increasing complexities and computational burdens (Verbeke et al. 2014), in this
development, we utilized the benefits of latent trait approach to model the multivariate
longitudinal outcomes. The semiparametric latent trait modeling approach for the
multivariate longitudinal outcomes offers a parsimonious univariate solution to the
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problem. Our proposed joint model covers applications of sequential time-to-events
cases of both the same (recurrent) and different types. For recurrent events, our model
estimates separate sets of effects sizes of the covariates for each occurrence of the
event in interest.
Despite the fact that this research attempts to fill an important gap in the statistical
joint modeling literature, the usage of the proposed model may be limited in certain
circumstances. For instance, due to using the latent trait approach of modeling the
multivariate longitudinal outcomes, the proposed model does not estimate any direct
effect of the covariates on longitudinal outcomes, rather, one gets indirect measures
of such covariate effects through the latent trait. The direct effects of the individual
longitudinal outcomes on the time-to-event risks are also not obtainable, indirect
effects through the the latent trait are estimated instead. In regards to the study
design and collection of data, applications of our proposed model require the measures
on the multivariate longitudinal outcomes to be collected at the same time-points to
get the value of latent trait at that time-point. The proposed model in this current
study assumes the right censoring times for individuals to be independent of the event
times and ignores the presence of any dependent censoring possibly due to a terminal
time-to-event.
We have presented a fully Bayesian approach of estimating the parameters of the
proposed model and considered a Bayesian MCMC approach for making the dynamic
predictions. The parameter estimation and the dynamic prediction algorithms were
found, through simulation studies, to perform satisfactorily. An application of the
proposed model reported differentials in viral load rebound risks with respect to the
demographic and clinical characteristics among the HIV/AIDS patients in SC.
Despite the certain limitations of the proposed model, this research is expected to
fill an important gap in the statistical joint modeling literature for jointly analyzing




In many biomedical studies, longitudinal outcomes and time-to-events data are col-
lected simultaneously. Utilization of both of these types of information, and accounting
for the correlation from all sources in modeling these data as well as in the prediction
processes are of significant statistical and medical interest. Traditional methods to
analyze these data are often based on separate models for the two types of data
including mixed-effects model for longitudinal outcomes and Cox hazard models with
using the longitudinal outcomes as time-dependent covariates for the time-to-events.
Such approach relies on strong assumptions in the time-to-event model that the mea-
surements of longitudinal outcomes are time-continuous processes, and the outcomes
are accurately measured without error. In practice, however, these assumptions are
challenging to be met. The longitudinal outcomes almost never continuously measured
due to cost and difficulties in implementation. The longitudinally measured outcomes
are nearly always sparse in time with a limited number of observations for each
individual. Longitudinal outcomes are sometimes measured imperfectly, with resulting
non-ignorable measurement errors. Given these practical inconveniences, studies have
shown that the analyses of such data using the traditional Cox model may provide
biased and inefficient results (Schafer and Graham 2002; Guo and Carlin 2004).
The introduction of the concept of jointly modeling the longitudinal outcomes and
the time-to-events data (Self and Pawitan 1992; DeGruttola and Tu 1992; De Gruttola
and Tu 1994; Faucett and Thomas 1996; Wulfsohn and Tsiatis 1997) provided a
very effective option to analyze the data in concern and to obtain valid inferences on
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both the longitudinal and time-to-event processes. The basic idea of joint modeling
is to model the longitudinal outcomes and time-to-events using different submodels
and linking them using shared parameters. For the last two decades, the areas of
research on statistical joint modeling have been very active, and vast extensions
and developments have been made. The body of joint modeling literature has seen
developments and extensions in different aspects of the modeling framework including
the maximum allowed number and types of both the longitudinal outcomes and
time-to-events, approaches of submodels for the longitudinal outcomes and time-to-
events, approaches to link the longitudinal and time-to-event submodels, and types
of censoring scheme assumed in time-to-events submodels. Detail reviews of these
works have been presented by many authors (e.g., Tsiatis and Davidian 2004; Diggle,
Sousa, and Chetwynd 2008; Sousa 2011; Proust-Lima et al. 2014; Lawrence Gould
et al. 2015; Hickey et al. 2016; Hickey et al. 2018).
Based on the current literature, it is evident that the majority of the previous joint
modeling research focused on improving the framework involving a single longitudinal
outcomes and a single time-to-event. Despite being observed in many clinical follow-
up studies, especially among the chronic disease patients, the methods of jointly
analyzing multivariate longitudinal outcomes and multiple time-to-event have been
remained understudied. Among the few studies focused on this problem previously
are very limited in practical applications either due to being developed only for two
time-to-events, or ignoring the correlations among the time-to-events, or ignoring the
presence of any possible dependent censoring mechanism.
While speaking of the joint models for multiple time-to-event, one other area
not discussed in current literature is the joint analysis of longitudinal outcomes and
multiple time-to-event of ordered/sequential nature and especially of not the same
type. A good body of joint modeling extensions and developments have considered
the problems of sequential time-to-events of the same kind, referred to as recurrent
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events however, these methods do not apply to the situations when the sequential
time-to-events are of different types. Even in the problems of recurrent time-to-events
where the different occurrences of the event may be impacted differently by the
underlying covariates, the existing joint models may not be applicable.
Given the limitations in current body of statistical joint modeling literature, in
this dissertation, we presented efforts providing joint modeling extensions with the
potentials of filling in the gaps. In this concluding chapter, we summarize the specific
contributions made, and some avenues of future research will also be discussed.
In Chapter 2 of this research work, we presented a shared parameter Bayesian
latent trait joint frailty model for analyzing multivariate longitudinal outcomes and
multiple unordered non-terminal time-to-events in the presence of a terminal event
inducing dependent right censoring. Given the growing complexities of joint models
involving multivariate longitudinal outcomes due to growing number of random-effects
(Verbeke et al. 2014), we adopted a semiparametric latent trait generalized mixed-
effects modeling approach to define the longitudinal submodel. The latent trait
approach provides a parsimonious longitudinal submodel by reducing the problem of
modeling the multivariate longitudinal outcomes to a univariate latent trait modeling.
We used individual semiparametric hazard models for the non-terminal and terminal
time-to-events. We used frailties in each of the non-terminal time-to-event submodels,
and the frailty correlations have been assumed to express the associations between the
non-terminal time-to-events. The effects of the non-terminal events on the terminal
event risk are estimated through the frailties as covariates in the terminal event
submodel. The longitudinal outcomes and the time-to-event submodels are linked
using a current value shared parameters approach through the latent trait.
In Chapter 4, we extended our interest in the problem of jointly analyzing multivari-
ate longitudinal outcomes and multiple ordered/sequential time-to-event of different
types. Following the similar approach presented in Chapter 2, we proposed a Bayesian
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latent trait joint frailty model for analyzing such data. The multivariate longitudinal
outcomes were modeled through a semiparametric latent trait generalized mixed-effects
approach for parsimony and sequential event gap times were modeled through semi-
parametric hazard regressions with frailties accounting for the correlations between
the events under the assumption of frailties being independent of the covariates. In
this proposed model, we also have used the previous events’ gap times as covariates to
assess their direct effects on a following event. The proposed joint model in Chapter
4 offers a modeling solution to the problems of joint analysis of longitudinal and
sequential time-to-events data, which has never been discussed in existing literature
except in the form of recurrent events. Our proposed model provides a more general
framework and applicable to both sequential time-to-events of the same and different
types. Analyses can be benefited using the proposed model when the recurrent events
are believed to be affected by the covariates differently at each occurrence.
In both the cases of the proposed joint models for unordered and sequential
time-to-events, we used fully Bayesian approaches of parameter estimation for easy
implementations. The other contributions we made in this study include outlining and
implementing the Bayesian MCMC dynamic prediction algorithms for longitudinal
outcomes and time-to-event risks using the estimated models. The dynamic prediction
algorithms in the existing joint modeling literature are mostly limited to joint models of
a single longitudinal outcome and a single time-to-event only. We presented simulation
studies showing satisfactory performances of estimating the model parameters as well as
making dynamic predictions. We also have demonstrated applications of our proposed
models using demographic and clinical characteristics, disease biomarkers, treatment,
morbidity, and mortality surveillance data collected from statewide HIV/AIDS patients
diagnosed from 2004 to 2013 in South Carolina.
While the proposed joint models in Chapter 2 and Chapter 4 offer more compre-
hensive, than the existing approaches, and widely applicable solutions to analyze the
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data in respective concerns, we also have discussed the specific limitations of them.
The main limitations of both of the proposed models stemmed from the latent trait
approach of modeling the multivariate longitudinal outcomes. The proposed models
do not estimate the direct effects of the covariates on the longitudinal outcomes. No
direct effects of the longitudinal outcomes on the time-to-event risks are not estimated
as well. However, in both the cases, the proposed models provide estimates of indirect
effects of the covariates and longitudinal outcomes on the longitudinal outcomes and
time-to-event risks, respectively, through the latent trait. A further limitation of the
joint model we proposed for the sequential time-to-events that it does not account for
the presence of any terminal event and consequently ignores the possibility of induced
dependent censoring due to such a terminal event.
Both of our propositions in Chapter 2 and Chapter 4 leaves and opens avenues
for future research. The joint model we proposed in Chapter 2 for multivariate
longitudinal outcomes and multiple unordered time-to-event and a terminal event
can incorporate longitudinal outcomes of different types. However, the continuous
numeric type longitudinal outcomes are assumed to be normally distributed. As in
some situations, such longitudinal outcomes may considerably deviate from normal
distributions and may be skewed, further research may be carried out to handle
such non-normally distributed continuous longitudinal outcomes. Tang and Tang
(2015) and Tang, Tang, and Zhu (2017) recently used an assumption of skewed-normal
distribution instead of normal for modeling non-normal longitudinal responses. The
models proposed in this study can also be extended in such a way to accommodate
the analyses of longitudinal outcomes with skewed distributions. Aligned with most
other developments in literature, our proposed models also have assumed the random-
effects in the longitudinal outcomes submodels to be normally distributed. In some
certain situations, such assumption may lead to misspecification of the random-effects
and eventually may adversely affect the inferences. Authors (e.g., Rizopoulos and
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Ghosh 2011; Tang, Tang, and Pan 2014; Tang and Tang 2015; Tang, Tang, and Zhu
2017) have employed alternative approach to avoid this caveat by using Dirichlet
process prior for the random-effects within a Bayesian framework. Our proposed joint
models in Chapter 2 and Chapter 4 can also be extended to relax the assumption of
normality for the random-effects distributions. One further normality assumption
we have used for the frailties accounting for correlations between the time-to-events
in both of our propositions in Chapter 2 and Chapter 4. Further research may be
necessary to examine the possibilities of relaxing such assumptions as well. The
proposed joint model in Chapter 4 for multivariate longitudinal outcomes and multiple
sequential time-to-event did not consider the presence of any terminal event in the
data generating process. Further research can be carried out to extend the proposed
model to be applicable in situations where the non-terminal sequential time-to-events
may be dependently censored by a terminal event. Further research may also be
needed to extend the proposed model in Chapter 4 for covering the practical situations
where each of the sequential time-to-events can assume a recurrent nature. Further
research also can extend both the proposed models in Chapter 2 and Chapter 4 by
using change-point model to capture the changes in longitudinal outcomes trajectory
after observing each of non-terminal time-to-events.
While the Chapter 2 and Chapter 4 of this dissertation focused on finding and filling
in gaps in the current joint modeling and dynamic prediction literature concerning
multivariate longitudinal outcomes and multiple time-to-event of both unordered and
ordered nature, Chapter 3 of this research looked upon the problem of estimating
marginal and conditional survival functions for multiple sequentially observed time-to-
events. Chapter 3 presented two very easy and straightforward methods of estimating
such survival functions under certain assumptions. The first of these two presented
approaches is non-parametric and assumes independence between the consecutive event
times to provide an easy estimator based on Kaplan-Meier estimates for the marginal
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survival functions of sequential time-to-events. The second approach, being fully
parametric, applies to the problems where sequentially observed time-to-events can not
be assumed to be independent. The parametric approach assumes the event times to
be multivariate log-normally distributed and uses a likelihood maximization approach
of estimating the associated parameters that provide the estimates of marginal and
conditional survival functions for the time-to-events. Statistical simulations and real-
data applications have been presented for both approaches. None of the approaches
that we presented in Chapter 3 considered any covariate effects while estimating
the survival functions. Further research are needed to develop covariate dependent
versions of both of our discussed approaches.
This dissertation has identified and offered solutions to certain gaps in statistical
literature concerning analyses of complex data involving multivariate longitudinal
data as well as multiple time-to-event of both unordered and ordered nature. Despite
the certain limitations of the proposed methods presented in this research works, they
are expected to make valuable additions to the existing body of related literature.
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